Biochemical	O
characterization	O
of	O
the	O
NF-Y	B-protein
transcription	I-protein
factor	I-protein
complex	I-protein
during	O
B	O
lymphocyte	O
development	O
.	O

The	O
transcription	B-protein
factor	I-protein
,	O
NF-Y	B-protein
,	O
plays	O
a	O
critical	O
role	O
in	O
tissue-specific	O
major	B-DNA
histocompatibility	I-DNA
complex	I-DNA
class	I-DNA
II	I-DNA
gene	I-DNA
transcription	O
.	O

In	O
this	O
report	O
the	O
biochemical	O
properties	O
of	O
the	O
heterotrimeric	B-protein
NF-Y	I-protein
complex	I-protein
have	O
been	O
characterized	O
during	O
stage-specific	O
B-cell	O
development	O
,	O
and	O
in	O
several	O
class	B-cell_line
II-	I-cell_line
mutant	I-cell_line
B-cell	I-cell_line
lines	I-cell_line
,	O
which	O
represent	O
distinct	O
bare	O
lymphocyte	O
syndrome	O
class	O
II	O
genetic	O
complementation	O
groups	O
.	O

The	O
NF-Y	B-protein
complex	I-protein
derived	O
from	O
class	B-cell_type
II+	I-cell_type
mature	I-cell_type
B-cells	I-cell_type
bound	O
with	O
high	O
affinity	O
to	O
anion	B-protein
exchangers	I-protein
,	O
and	O
eluted	O
as	O
an	O
intact	O
trimeric	B-protein
complex	I-protein
,	O
whereas	O
,	O
NF-Y	B-protein
derived	O
from	O
class	B-cell_type
II-	I-cell_type
plasma	I-cell_type
B-cells	I-cell_type
,	O
and	O
from	O
bare	B-cell_line
lymphocyte	I-cell_line
syndrome	I-cell_line
group	I-cell_line
II	I-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
RJ2.2.5	B-cell_line
and	O
RM3	B-cell_line
,	O
dissociated	O
into	O
discrete	O
NF-YA	B-protein
and	O
NF-YB	B-protein
:	I-protein
C	I-protein
subunit	B-protein
fractions	I-protein
.	O

Recombination	O
of	O
the	O
MPC11	B-protein
plasma	I-protein
B-cell	I-protein
derived	I-protein
NF-Y	I-protein
A	I-protein
:	I-protein
B	I-protein
:	I-protein
C	I-protein
complex	I-protein
with	O
the	O
low	O
molecular	O
mass	O
protein	O
fraction	O
,	O
NF-Y-associated	B-protein
factors	I-protein
(	O
YAFs	B-protein
)	O
,	O
derived	O
from	O
mature	O
A20	O
B-cell	O
nuclei	O
,	O
conferred	O
high	O
affinity	O
anion	O
exchange	O
binding	O
to	O
NF-Y	B-protein
as	O
an	O
intact	B-protein
trimeric	I-protein
complex	I-protein
.	O

Recombination	O
of	O
the	O
native	B-protein
NF-YA	I-protein
:	I-protein
B	I-protein
:	I-protein
C	I-protein
complex	I-protein
with	O
the	O
transcriptional	B-protein
cofactor	I-protein
,	O
PC4	B-protein
,	O
likewise	O
conferred	O
high	B-protein
affinity	I-protein
NF-Y	I-protein
binding	O
to	O
anion	B-protein
exchangers	I-protein
,	O
and	O
stabilized	O
NF-Y	B-protein
interaction	O
with	O
CCAAT-box	B-DNA
DNA	I-DNA
motifs	I-DNA
in	O
vitro	O
.	O

Interaction	O
between	O
PC4	B-protein
and	O
NF-Y	B-protein
was	O
mapped	O
to	O
the	O
C-terminal	B-protein
region	I-protein
of	O
PC4	B-protein
,	O
and	O
the	O
subunit	B-protein
interaction	I-protein
subdomain	I-protein
of	O
the	O
highly	B-protein
conserved	I-protein
DNA	I-protein
binding-subunit	I-protein
interaction	I-protein
domain	I-protein
(	O
DBD	B-protein
)	O
of	O
NF-YA	B-protein
.	O

These	O
results	O
suggest	O
that	O
in	O
class	B-cell_type
II+	I-cell_type
mature	I-cell_type
B-cells	I-cell_type
NF-Y	B-protein
is	O
associated	O
with	O
the	O
protein	O
cofactor	O
,	O
PC4	B-protein
,	O
which	O
may	O
play	O
an	O
important	O
role	O
in	O
NF-Y-mediated	O
transcriptional	O
control	O
of	O
class	B-DNA
II	I-DNA
genes	I-DNA
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Â©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

273	NULL
,	NULL
No	NULL
.	NULL

29	NULL
,	NULL
Issue	NULL
of	NULL
July	NULL
17	NULL
,	NULL
pp	NULL
.	NULL

18220-18229	NULL
,	NULL
1998	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Biochemical	NULL
Characterization	NULL
of	NULL
the	NULL
NF-Y	NULL
Transcription	NULL
Factor	NULL
Complex	NULL
during	NULL
B	NULL
Lymphocyte	NULL
Development*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
March	NULL
31	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
May	NULL
13	NULL
,	NULL
1998	NULL
)	NULL
R.	NULL
Alexander	NULL
Currie	NULL
}	NULL
From	NULL
the	NULL
Laboratory	NULL
of	NULL
Gene	NULL
Regulation	NULL
,	NULL
The	NULL
Wheeler	NULL
Institute	NULL
for	NULL
Biomedical	NULL
Research	NULL
,	NULL
Huntington	NULL
,	NULL
New	NULL
York	NULL
11743	NULL
The	NULL
transcription	NULL
factor	NULL
,	NULL
NF-Y	NULL
,	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
tissue-specific	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
this	NULL
report	NULL
the	NULL
biochemical	NULL
properties	NULL
of	NULL
the	NULL
heterotrimeric	NULL
NF-Y	NULL
complex	NULL
have	NULL
been	NULL
characterized	NULL
during	NULL
stage-specific	NULL
B-cell	NULL
development	NULL
,	NULL
and	NULL
in	NULL
several	NULL
class	NULL
IIC	NULL
mutant	NULL
B-cell	NULL
lines	NULL
,	NULL
which	NULL
represent	NULL
distinct	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
class	NULL
II	NULL
genetic	NULL
complementation	NULL
groups	NULL
.	NULL

The	NULL
NF-Y	NULL
complex	NULL
derived	NULL
from	NULL
class	NULL
II*	NULL
mature	NULL
B-cells	NULL
bound	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
anion	NULL
exchangers	NULL
,	NULL
and	NULL
eluted	NULL
as	NULL
an	NULL
intact	NULL
trimeric	NULL
complex	NULL
,	NULL
whereas	NULL
,	NULL
NF-Y	NULL
derived	NULL
from	NULL
class	NULL
II~	NULL
plasma	NULL
B-cells	NULL
,	NULL
and	NULL
from	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
group	NULL
II	NULL
cell	NULL
lines	NULL
,	NULL
RJ2.2.5	NULL
and	NULL
RM3	NULL
,	NULL
dissociated	NULL
into	NULL
discrete	NULL
NF-YA	NULL
and	NULL
NF-YB	NULL
:	NULL
C	NULL
subunit	NULL
fractions	NULL
.	NULL

Recombination	NULL
of	NULL
the	NULL
MPC11	NULL
plasma	NULL
B-cell	NULL
derived	NULL
NF-Y	NULL
A	NULL
:	NULL
B	NULL
:	NULL
C	NULL
complex	NULL
with	NULL
the	NULL
low	NULL
molecular	NULL
mass	NULL
protein	NULL
fraction	NULL
,	NULL
NF-Y-associated	NULL
factors	NULL
(	NULL
YAFs	NULL
)	NULL
,	NULL
derived	NULL
from	NULL
mature	NULL
A20	NULL
B-cell	NULL
nuclei	NULL
,	NULL
conferred	NULL
high	NULL
affinity	NULL
anion	NULL
exchange	NULL
binding	NULL
to	NULL
NF-Y	NULL
as	NULL
an	NULL
intact	NULL
trimeric	NULL
complex	NULL
.	NULL

Recombination	NULL
of	NULL
the	NULL
native	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
complex	NULL
with	NULL
the	NULL
transcriptional	NULL
cofactor	NULL
,	NULL
PC4	NULL
,	NULL
likewise	NULL
conferred	NULL
high	NULL
affinity	NULL
NF-Y	NULL
binding	NULL
to	NULL
anion	NULL
exchangers	NULL
,	NULL
and	NULL
stabilized	NULL
NF-Y	NULL
interaction	NULL
with	NULL
CCAAT-box	NULL
DNA	NULL
motifs	NULL
in	NULL
vitro	NULL
.	NULL

Interaction	NULL
between	NULL
PC4	NULL
and	NULL
NF-Y	NULL
was	NULL
mapped	NULL
to	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
PC4	NULL
,	NULL
and	NULL
the	NULL
subunit	NULL
interaction	NULL
subdomain	NULL
of	NULL
the	NULL
highly	NULL
conserved	NULL
DNA	NULL
binding-subunit	NULL
interaction	NULL
domain	NULL
(	NULL
DBD	NULL
)	NULL
of	NULL
NF-YA	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
class	NULL
II*	NULL
mature	NULL
B-cells	NULL
NF-Y	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
protein	NULL
cofactor	NULL
,	NULL
PC4	NULL
,	NULL
which	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
NF-Y-mediated	NULL
transcriptional	NULL
control	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

The	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
II	NULL
genes	NULL
encode	NULL
a	NULL
set	NULL
of	NULL
highly	NULL
polymorphic	NULL
transmembrane	NULL
glycopro-teins	NULL
that	NULL
mediate	NULL
several	NULL
critical	NULL
immunological	NULL
processes	NULL
that	NULL
include	NULL
antigen	NULL
presentation	NULL
to	NULL
T	NULL
helper	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
phenomenon	NULL
of	NULL
T-cell	NULL
selection	NULL
in	NULL
the	NULL
thymus	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

MHC	NULL
class	NULL
II	NULL
a	NULL
and	NULL
B	NULL
subunits	NULL
form	NULL
a	NULL
non	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
AI87686	NULL
from	NULL
NIAID	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.9.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

J	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
MHC	NULL
,	NULL
major	NULL
histocompatibility	NULL
com-plex	NULL
;	NULL
RFX	NULL
,	NULL
regulatory	NULL
factor	NULL
X	NULL
;	NULL
CREB	NULL
,	NULL
cyclic	NULL
AMP	NULL
response	NULL
element-binding	NULL
protein	NULL
;	NULL
NF-Y	NULL
,	NULL
nuclear	NULL
factor-Y	NULL
;	NULL
C/EBP	NULL
,	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
;	NULL
SREBP	NULL
,	NULL
sterol	NULL
regulatory	NULL
element-binding	NULL
protein	NULL
;	NULL
HMG-CoA	NULL
,	NULL
3-hydroxy-3-methylglutaryl-coenzyme	NULL
A	NULL
;	NULL
CBF	NULL
,	NULL
CCAAT-binding	NULL
factor	NULL
;	NULL
DBD	NULL
,	NULL
DNA	NULL
binding-subunit	NULL
interaction	NULL
domain	NULL
;	NULL
BLS	NULL
,	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
;	NULL
CITA	NULL
,	NULL
class	NULL
II	NULL
transactivator	NULL
;	NULL
IFN-y	NULL
,	NULL
in-terferon-y	NULL
;	NULL
PC4	NULL
,	NULL
positive	NULL
cofactor	NULL
4	NULL
;	NULL
CKII	NULL
,	NULL
casein	NULL
kinase	NULL
II	NULL
;	NULL
YAF	NULL
,	NULL
NF-Y-associated	NULL
factors	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
HMK	NULL
,	NULL
heart	NULL
muscle	NULL
creatine	NULL
kinase	NULL
;	NULL
BSA	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
EtBr	NULL
,	NULL
ethidium	NULL
bromide	NULL
;	NULL
TBP	NULL
,	NULL
TATA-binding	NULL
protein	NULL
.	NULL

18220	NULL
covalent	NULL
heterodimer	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
a	NULL
restricted	NULL
subset	NULL
of	NULL
mammalian	NULL
cell	NULL
types	NULL
(	NULL
e.g	NULL
.	NULL

mature	NULL
B-cells	NULL
,	NULL
activated	NULL
T-cells	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
the	NULL
thymic	NULL
epithelium	NULL
)	NULL
,	NULL
and	NULL
their	NULL
expression	NULL
is	NULL
modulated	NULL
at	NULL
the	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
levels	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
cytokines	NULL
,	NULL
lymphokines	NULL
,	NULL
and	NULL
hormones	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

3-6	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
in	NULL
B	NULL
lymphocytes	NULL
MHC	NULL
class	NULL
II	NULL
proteins	NULL
are	NULL
regulated	NULL
in	NULL
a	NULL
stage-specific	NULL
manner	NULL
,	NULL
as	NULL
the	NULL
high	NULL
level	NULL
of	NULL
constitutive	NULL
expression	NULL
observed	NULL
in	NULL
mature	NULL
B-cells	NULL
is	NULL
completely	NULL
extinguished	NULL
during	NULL
progression	NULL
to	NULL
the	NULL
plasma	NULL
B-cell	NULL
stage	NULL
through	NULL
repression	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Three	NULL
highly	NULL
conserved	NULL
MHC	NULL
class	NULL
II	NULL
DNA	NULL
elements	NULL
,	NULL
the	NULL
S-	NULL
,	NULL
X-	NULL
,	NULL
and	NULL
Y-boxes	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
through	NULL
extensive	NULL
functional	NULL
analyses	NULL
to	NULL
represent	NULL
,	NULL
in	NULL
large	NULL
measure	NULL
,	NULL
the	NULL
focal	NULL
regulatory	NULL
regions	NULL
of	NULL
class	NULL
II	NULL
transcriptional	NULL
control	NULL
(	NULL
9-12	NULL
)	NULL
.	NULL

The	NULL
X-box	NULL
contains	NULL
two	NULL
separable	NULL
functional	NULL
elements	NULL
:	NULL
X1	NULL
and	NULL
X2	NULL
,	NULL
where	NULL
the	NULL
X1	NULL
motif	NULL
binds	NULL
the	NULL
regulatory	NULL
factor	NULL
X	NULL
(	NULL
RFX	NULL
)	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
,	NULL
and	NULL
the	NULL
X2	NULL
motif	NULL
binds	NULL
many	NULL
members	NULL
of	NULL
the	NULL
fos/jun	NULL
and	NULL
cyclic	NULL
AMP	NULL
response	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
/activating	NULL
transcription	NULL
factor	NULL
families	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
single	NULL
activating	NULL
transcription	NULL
factor	NULL
,	NULL
the	NULL
heteromeric	NULL
nuclear	NULL
factor-Y	NULL
(	NULL
NF-Y	NULL
)	NULL
,	NULL
specifically	NULL
interacts	NULL
with	NULL
a	NULL
CCAAT	NULL
motif	NULL
found	NULL
in	NULL
all	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
Y-boxes	NULL
(	NULL
10	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Proteins	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
X-	NULL
and	NULL
Y-box	NULL
elements	NULL
function	NULL
in	NULL
a	NULL
cooperative	NULL
manner	NULL
because	NULL
alterations	NULL
in	NULL
their	NULL
spacing	NULL
lead	NULL
to	NULL
significant	NULL
reduction	NULL
in	NULL
in	NULL
vivo	NULL
promoter	NULL
activity	NULL
(	NULL
19	NULL
)	NULL
,	NULL
and	NULL
disrupt	NULL
stabilized	NULL
complexes	NULL
formed	NULL
in	NULL
vitro	NULL
with	NULL
their	NULL
corresponding	NULL
proteins	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

NF-Y	NULL
binding	NULL
sites	NULL
are	NULL
frequently	NULL
located	NULL
within	NULL
~50-80	NULL
base	NULL
pairs	NULL
of	NULL
promoter	NULL
transcriptional	NULL
initiation	NULL
sites	NULL
,	NULL
and	NULL
also	NULL
in	NULL
more	NULL
distal	NULL
enhancer	NULL
control	NULL
regions	NULL
of	NULL
eukaryotic	NULL
genes	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
these	NULL
contexts	NULL
,	NULL
the	NULL
ubiquitous	NULL
NF-Y	NULL
factor	NULL
is	NULL
often	NULL
juxtaposed	NULL
with	NULL
other	NULL
general	NULL
or	NULL
tissue-restricted	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
together	NULL
mediate	NULL
crucial	NULL
functional	NULL
steps	NULL
in	NULL
constitutive	NULL
and	NULL
inducible	NULL
gene	NULL
regulation	NULL
.	NULL

For	NULL
example	NULL
,	NULL
cooperative	NULL
protein	NULL
interactions	NULL
between	NULL
NF-Y	NULL
and	NULL
the	NULL
CCAAT/en-hancer-binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
,	NULL
and	NULL
C/EBP-related	NULL
proteins	NULL
,	NULL
DBP	NULL
and	NULL
LAP	NULL
,	NULL
have	NULL
been	NULL
observed	NULL
in	NULL
the	NULL
murine	NULL
albumin	NULL
promoter	NULL
(	NULL
23	NULL
)	NULL
,	NULL
between	NULL
NF-Y	NULL
and	NULL
the	NULL
serum	NULL
response	NULL
factor	NULL
,	NULL
p67Â°	NULL
``	NULL
``	NULL
,	NULL
in	NULL
the	NULL
human	NULL
G-actin	NULL
promoter	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
between	NULL
the	NULL
NF-Y	NULL
and	NULL
the	NULL
sterol	NULL
regulatory	NULL
element-binding	NULL
protein	NULL
(	NULL
SREBP	NULL
)	NULL
in	NULL
the	NULL
3-hydroxy-3-methylglutaryl-coenzyme	NULL
A	NULL
(	NULL
HMG-CoA	NULL
)	NULL
promoter	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
the	NULL
last	NULL
example	NULL
,	NULL
NF-Y	NULL
:	NULL
SREBP	NULL
acts	NULL
as	NULL
a	NULL
negative-feedback	NULL
sensor	NULL
to	NULL
regulate	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
HMG-CoA	NULL
in	NULL
response	NULL
to	NULL
serum	NULL
cholesterol	NULL
levels	NULL
.	NULL

Initial	NULL
biochemical	NULL
characterization	NULL
of	NULL
the	NULL
HeLa	NULL
cell	NULL
CCAAT-box	NULL
factor	NULL
,	NULL
CPI	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
the	NULL
rat	NULL
liver	NULL
CCAAT-box	NULL
factor	NULL
(	NULL
CBF	NULL
)	NULL
(	NULL
27	NULL
)	NULL
,	NULL
showed	NULL
that	NULL
specific	NULL
CCAAT-box	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
lost	NULL
following	NULL
ion	NULL
exchange	NULL
chromatography	NULL
,	NULL
but	NULL
could	NULL
be	NULL
restored	NULL
by	NULL
recombining	NULL
two	NULL
separate	NULL
column	NULL
fractions	NULL
.	NULL

The	NULL
two	NULL
HeLa	NULL
column	NULL
fractions	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
could	NULL
also	NULL
be	NULL
recombined	NULL
with	NULL
the	NULL
separated	NULL
Saccharomyces	NULL
cerevisiae	NULL
subunit	NULL
fractions	NULL
,	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
NF-Y	NULL
-associated	NULL
Cofactors	NULL
in	NULL
Stage-specific	NULL
B-cells	NULL
HAP2	NULL
and	NULL
HAP3	NULL
,	NULL
to	NULL
reconstitute	NULL
specific	NULL
CCAAT-box	NULL
binding	NULL
activity	NULL
(	NULL
28	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
a	NULL
heterodimeric	NULL
structure	NULL
for	NULL
this	NULL
CCAAT	NULL
factor	NULL
,	NULL
which	NULL
appeared	NULL
to	NULL
have	NULL
been	NULL
highly	NULL
conserved	NULL
in	NULL
eukaryotes	NULL
(	NULL
26-29	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
cDNAs	NULL
that	NULL
encoded	NULL
the	NULL
murine	NULL
NF-YA/YB	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
rat	NULL
CBF-A	NULL
(	NULL
NF-YB	NULL
)	NULL
,	NULL
and	NULL
CBF-B	NULL
(	NULL
NF-YA	NULL
)	NULL
subunits	NULL
(	NULL
30-32	NULL
)	NULL
provided	NULL
conclusive	NULL
evidence	NULL
of	NULL
the	NULL
equivalence	NULL
of	NULL
CBF	NULL
and	NULL
NF-Y	NULL
,	NULL
and	NULL
showed	NULL
these	NULL
subunits	NULL
to	NULL
be	NULL
homologs	NULL
of	NULL
the	NULL
yeast	NULL
HAP2/3	NULL
proteins	NULL
(	NULL
83-35	NULL
)	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
additional	NULL
S.	NULL
cerevisice	NULL
factor	NULL
,	NULL
HAP5	NULL
(	NULL
86	NULL
)	NULL
,	NULL
and	NULL
CBF-C	NULL
(	NULL
NF-YC	NULL
)	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
together	NULL
with	NULL
biochemical	NULL
characterization	NULL
of	NULL
the	NULL
NF-Y	NULL
complex	NULL
,	NULL
has	NULL
now	NULL
confirmed	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
third	NULL
subunit	NULL
and	NULL
a	NULL
heterotrimeric	NULL
structure	NULL
which	NULL
is	NULL
minimally	NULL
required	NULL
for	NULL
specific	NULL
CCAAT-box	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
NF-Y	NULL
complex	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
functionally	NULL
with	NULL
the	NULL
non-histone	NULL
chromosomal	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
and	NULL
a	NULL
protein-protein	NULL
interaction	NULL
site	NULL
mapped	NULL
to	NULL
the	NULL
NF-YA	NULL
DNA-subunit	NULL
interaction	NULL
domain	NULL
(	NULL
DBD	NULL
)	NULL
in	NULL
NF-Y	NULL
,	NULL
and	NULL
the	NULL
AT-hook	NULL
motif	NULL
in	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
(	NULL
89	NULL
)	NULL
.	NULL

Lack	NULL
of	NULL
appropriate	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
in	NULL
humans	NULL
results	NULL
in	NULL
a	NULL
severe	NULL
autosomal	NULL
recessive	NULL
immunodeficient	NULL
condition	NULL
known	NULL
as	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
(	NULL
BLS	NULL
)	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
class	NULL
II~	NULL
mutant	NULL
B-cells	NULL
in	NULL
BLS	NULL
subgroup	NULL
type	NULL
II	NULL
synthesize	NULL
normal	NULL
levels	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
,	NULL
and	NULL
class	NULL
-associated	NULL
invariant	NULL
chain	NULL
proteins	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
all	NULL
class	NULL
II	NULL
isotypes	NULL
is	NULL
universally	NULL
extinguished	NULL
.	NULL

The	NULL
B-cell-specific	NULL
gene	NULL
product	NULL
,	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CIITA	NULL
)	NULL
,	NULL
represents	NULL
the	NULL
defective	NULL
gene	NULL
product	NULL
in	NULL
BLS	NULL
group	NULL
II	NULL
class	NULL
II~	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
is	NULL
capable	NULL
of	NULL
fully	NULL
restoring	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
in	NULL
this	NULL
specific	NULL
genetic	NULL
complementation	NULL
group	NULL
(	NULL
40	NULL
)	NULL
.	NULL

CIITA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
both	NULL
constitutive	NULL
class	NULL
II	NULL
transcription	NULL
in	NULL
mature	NULL
B-cells	NULL
(	NULL
40	NULL
)	NULL
,	NULL
and	NULL
mediate	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
-induced	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
during	NULL
monocyte/macrophage	NULL
cell	NULL
differentiation	NULL
,	NULL
and	NULL
in	NULL
several	NULL
class	NULL
II~	NULL
cell	NULL
lines	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
endog-enous	NULL
CIITA	NULL
mRNA	NULL
expression	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
completely	NULL
suppressed	NULL
in	NULL
plasma	NULL
B-cells	NULL
,	NULL
whereas	NULL
unregulated	NULL
overexpression	NULL
of	NULL
CIITA	NULL
in	NULL
plasma	NULL
B-cells	NULL
surprisingly	NULL
restores	NULL
MHC	NULL
class	NULL
II	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
to	NULL
the	NULL
elevated	NULL
levels	NULL
observed	NULL
in	NULL
mature	NULL
B-cells	NULL
(	NULL
43	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
active	NULL
repression	NULL
of	NULL
CIITA	NULL
expression	NULL
accounts	NULL
for	NULL
the	NULL
dominant	NULL
suppressor	NULL
plasma	NULL
cell	NULL
phenotype	NULL
exhibited	NULL
by	NULL
mature	NULL
B	NULL
:	NULL
plasma	NULL
B-cell	NULL
somatic	NULL
cell	NULL
hybrids	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
,	NULL
and	NULL
further	NULL
suggest	NULL
CIITA	NULL
plays	NULL
an	NULL
obligatory	NULL
role	NULL
in	NULL
the	NULL
normal	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
.	NULL

Positive	NULL
cofactor	NULL
4	NULL
(	NULL
PC4	NULL
)	NULL
,	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
p15	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
,	NULL
was	NULL
initially	NULL
identified	NULL
as	NULL
an	NULL
abundant	NULL
nuclear	NULL
protein	NULL
in	NULL
murine	NULL
plasmacytoma	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
,	NULL
and	NULL
cloned	NULL
independently	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
its	NULL
differential	NULL
expression	NULL
in	NULL
rat	NULL
embryo	NULL
cells	NULL
and	NULL
B-cell	NULL
tumors	NULL
(	NULL
47	NULL
)	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
protein	NULL
to	NULL
bind	NULL
polydeoxy-pyrimidines	NULL
in	NULL
vitro	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
PC4/p15	NULL
was	NULL
shown	NULL
to	NULL
function	NULL
as	NULL
a	NULL
general	NULL
transcription	NULL
accessory	NULL
factor	NULL
in	NULL
the	NULL
response	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
to	NULL
upstream	NULL
activator	NULL
proteins	NULL
in	NULL
in	NULL
vitro	NULL
reconstituted	NULL
systems	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Phosphorylated	NULL
PC4	NULL
,	NULL
as	NULL
modified	NULL
by	NULL
casein	NULL
kinase	NULL
II	NULL
(	NULL
CKII	NULL
)	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
functionally	NULL
inactive	NULL
in	NULL
reconstituted	NULL
cell-free	NULL
in	NULL
vitro	NULL
transcription	NULL
assays	NULL
,	NULL
whereas	NULL
both	NULL
the	NULL
purified	NULL
native	NULL
non-phos-phorylated	NULL
,	NULL
and	NULL
Escherichia	NULL
coli	NULL
derived	NULL
forms	NULL
of	NULL
PC4	NULL
,	NULL
are	NULL
potent	NULL
transcriptional	NULL
activators	NULL
in	NULL
vitro	NULL
(	NULL
45	NULL
,	NULL
48	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
recent	NULL
results	NULL
suggest	NULL
that	NULL
PC4	NULL
regulation	NULL
may	NULL
occur	NULL
while	NULL
tethered	NULL
to	NULL
specific	NULL
promoter	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
NF-Y	NULL
(	NULL
39	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
the	NULL
biochemical	NULL
ion	NULL
exchange	NULL
properties	NULL
of	NULL
the	NULL
NF-Y	NULL
complex	NULL
were	NULL
examined	NULL
in	NULL
stage-specific	NULL
B	NULL
lymphocytes	NULL
,	NULL
and	NULL
compared	NULL
with	NULL
a	NULL
series	NULL
of	NULL
BLS	NULL
mutant	NULL
cell	NULL
lines	NULL
to	NULL
determine	NULL
if	NULL
tissue-specific	NULL
changes	NULL
in	NULL
NF-Y	NULL
structure	NULL
occur	NULL
during	NULL
stages	NULL
of	NULL
active	NULL
and	NULL
inactive	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
NF-Y	NULL
complex	NULL
in	NULL
class	NULL
II*	NULL
mature	NULL
B	NULL
lymphocytes	NULL
was	NULL
18221	NULL
observed	NULL
to	NULL
bind	NULL
as	NULL
an	NULL
intact	NULL
trimeric	NULL
complex	NULL
to	NULL
anion	NULL
exchangers	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
NF-Y	NULL
complex	NULL
derived	NULL
from	NULL
class	NULL
II~	NULL
plasma	NULL
B-cells	NULL
dissociated	NULL
into	NULL
discrete	NULL
NF-YA	NULL
and	NULL
NF-YB	NULL
:	NULL
C	NULL
subunit	NULL
fractions	NULL
following	NULL
anion	NULL
exchange	NULL
chromatography	NULL
.	NULL

A	NULL
protein	NULL
fraction	NULL
derived	NULL
from	NULL
mature	NULL
B-cell	NULL
nuclei	NULL
,	NULL
the	NULL
NF-Y-associated	NULL
factors	NULL
(	NULL
YAFs	NULL
)	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
recombinant	NULL
PC4	NULL
,	NULL
restored	NULL
Q*	NULL
binding	NULL
to	NULL
the	NULL
plasma	NULL
B-cell	NULL
NF-Y	NULL
complex	NULL
as	NULL
an	NULL
intact	NULL
trimeric	NULL
complex	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
,	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
mature	NULL
B-cells	NULL
,	NULL
PC4	NULL
functions	NULL
to	NULL
stabilize	NULL
both	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
subunit	NULL
interactions	NULL
,	NULL
as	NULL
well	NULL
as	NULL
NF-Y	NULL
:	NULL
CCAAT-box	NULL
DNA	NULL
interactions	NULL
,	NULL
and	NULL
further	NULL
suggest	NULL
PC4	NULL
plays	NULL
important	NULL
trans-activator/transrepressor	NULL
roles	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
during	NULL
B-cell	NULL
development	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Recombinant	NULL
Plasmids-Human	NULL
PC4	NULL
was	NULL
cloned	NULL
from	NULL
pPCA4	NULL
2T	NULL
(	NULL
89	NULL
)	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pGEX2TK	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
using	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

GST-PC4	NULL
mutants	NULL
were	NULL
derived	NULL
from	NULL
pPC4	NULL
2T	NULL
using	NULL
polymerase	NULL
chain	NULL
reaction	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
BamHI-EcoRI	NULL
sites	NULL
of	NULL
pGEX2TK	NULL
.	NULL

pPCA4	NULL
(	NULL
AC37	NULL
)	NULL
contains	NULL
the	NULL
N-terminal	NULL
90	NULL
amino	NULL
acids	NULL
of	NULL
PC4	NULL
(	NULL
nucleotides	NULL
1-270	NULL
as	NULL
defined	NULL
;	NULL
Ref	NULL
.	NULL

44	NULL
)	NULL
,	NULL
pPCA4	NULL
(	NULL
AN64	NULL
)	NULL
contains	NULL
the	NULL
C-terminal	NULL
63	NULL
amino	NULL
acids	NULL
(	NULL
nucleotides	NULL
198-884	NULL
)	NULL
,	NULL
and	NULL
pPC4	NULL
(	NULL
C37	NULL
)	NULL
contains	NULL
the	NULL
C-terminal	NULL
37	NULL
amino	NULL
acids	NULL
of	NULL
PC4	NULL
(	NULL
nucleotides	NULL
271-384	NULL
)	NULL
.	NULL

pYA	NULL
(	NULL
DBDAC23	NULL
)	NULL
was	NULL
prepared	NULL
by	NULL
digesting	NULL
pYA	NULL
(	NULL
DBD	NULL
)	NULL
(	NULL
89	NULL
)	NULL
with	NULL
StyI-EcoRI	NULL
,	NULL
followed	NULL
by	NULL
treatment	NULL
with	NULL
the	NULL
large	NULL
subunit	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
(	NULL
Klenow	NULL
)	NULL
under	NULL
standard	NULL
conditions	NULL
to	NULL
generate	NULL
blunt-ends	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
purified	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
fragment	NULL
was	NULL
ligated	NULL
and	NULL
plasmids	NULL
that	NULL
lacked	NULL
the	NULL
C-terminal	NULL
28	NULL
amino	NULL
acids	NULL
of	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
(	NULL
nucleotides	NULL
1011-1081	NULL
,	NULL
as	NULL
defined	NULL
in	NULL
Ref	NULL
.	NULL

18	NULL
)	NULL
were	NULL
identified	NULL
.	NULL

Plasmids	NULL
were	NULL
prepared	NULL
and	NULL
verified	NULL
using	NULL
standard	NULL
techniques	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Expression	NULL
and	NULL
Purification	NULL
of	NULL
Recombinant	NULL
Proteins-	NULL
The	NULL
cloning	NULL
,	NULL
expression	NULL
,	NULL
and	NULL
purification	NULL
of	NULL
His-YÂ¥B	NULL
,	NULL
His-YC	NULL
,	NULL
glutathione	NULL
S-transfer-ase	NULL
(	NULL
GST	NULL
)	NULL
,	NULL
and	NULL
GST	NULL
fusion	NULL
proteins	NULL
(	NULL
YA	NULL
,	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
,	NULL
YA	NULL
(	NULL
ADBD	NULL
)	NULL
,	NULL
PC4	NULL
,	NULL
Dr1	NULL
,	NULL
TFIIB	NULL
,	NULL
and	NULL
HAP2	NULL
(	NULL
DBD	NULL
)	NULL
)	NULL
,	NULL
and	NULL
*Â°P	NULL
labeling	NULL
of	NULL
recombinant	NULL
proteins	NULL
using	NULL
CKII	NULL
,	NULL
and	NULL
heart	NULL
muscle	NULL
creatine	NULL
kinase	NULL
(	NULL
HMK	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
89	NULL
)	NULL
.	NULL

GST-PC4	NULL
(	NULL
AC37	NULL
)	NULL
,	NULL
GST-PC4	NULL
(	NULL
C37	NULL
)	NULL
,	NULL
GST-PC4	NULL
(	NULL
AN64	NULL
)	NULL
,	NULL
and	NULL
GST-YA	NULL
(	NULL
DBDAC23	NULL
)	NULL
were	NULL
expressed	NULL
in	NULL
K.	NULL
coli	NULL
DHS50	NULL
,	NULL
and	NULL
purified	NULL
from	NULL
the	NULL
soluble	NULL
fraction	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Thrombin	NULL
cleaved	NULL
recombinant	NULL
proteins	NULL
,	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
and	NULL
PC4	NULL
,	NULL
were	NULL
further	NULL
purified	NULL
to	NULL
>	NULL
95	NULL
%	NULL
by	NULL
centrifugation	NULL
through	NULL
Centricon	NULL
30	NULL
filtration	NULL
devices	NULL
(	NULL
Amicon	NULL
)	NULL
in	NULL
BC-420	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.42	NULL
M	NULL
KCl	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
Â°C	NULL
following	NULL
buffer	NULL
exchange	NULL
to	NULL
BC-100	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.1	NULL
M	NULL
KCl	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
)	NULL
using	NULL
Centricon	NULL
10	NULL
devices	NULL
(	NULL
Amicon	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Nuclear	NULL
Extract	NULL
Preparation-Cell	NULL
lines	NULL
were	NULL
kindly	NULL
provided	NULL
for	NULL
these	NULL
studies	NULL
as	NULL
follows	NULL
:	NULL
A20	NULL
(	NULL
J.	NULL
Durdik	NULL
,	NULL
University	NULL
of	NULL
Arkansas	NULL
,	NULL
Fayetteville	NULL
,	NULL
AR	NULL
)	NULL
,	NULL
Raji	NULL
(	NULL
J.	NULL
Jones	NULL
,	NULL
National	NULL
Jewish	NULL
Center	NULL
for	NULL
Immunology	NULL
and	NULL
Respiratory	NULL
Medicine	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
)	NULL
,	NULL
RJ2.2.5	NULL
(	NULL
B.	NULL
Mach	NULL
,	NULL
University	NULL
of	NULL
Geneva	NULL
,	NULL
Geneva	NULL
,	NULL
Switzerland	NULL
)	NULL
,	NULL
RM8	NULL
(	NULL
M.	NULL
Peterlin	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
6.1.6	NULL
(	NULL
D.	NULL
Pious	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

MPC11	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
ATCC	NULL
,	NULL
Rockille	NULL
,	NULL
MD	NULL
.	NULL

Lymphocyte	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
suspension	NULL
culture	NULL
at	NULL
~10Â°	NULL
cells/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
which	NULL
contained	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
HyClone	NULL
)	NULL
.	NULL

Cell	NULL
lines	NULL
were	NULL
routinely	NULL
tested	NULL
for	NULL
cell	NULL
surface	NULL
MHC	NULL
class	NULL
II	NULL
protein	NULL
using	NULL
FITC-conjugated	NULL
species-specific	NULL
anti-class	NULL
II	NULL
antibodies	NULL
(	NULL
PharMingen	NULL
)	NULL
and	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
analysis	NULL
.	NULL

A20	NULL
and	NULL
Raji	NULL
cells	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
surface	NULL
MHC	NULL
class	NULL
II	NULL
protein	NULL
,	NULL
whereas	NULL
all	NULL
other	NULL
class	NULL
II~	NULL
cell	NULL
lines	NULL
tested	NULL
did	NULL
not	NULL
express	NULL
measurable	NULL
surface	NULL
class	NULL
II	NULL
molecules	NULL
.	NULL
``	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
these	NULL
,	NULL
and	NULL
other	NULL
cell	NULL
lines	NULL
,	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
50	NULL
)	NULL
,	NULL
and	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
passed	NULL
over	NULL
DEAE-Sepharose	NULL
(	NULL
Sigma	NULL
)	NULL
in	NULL
BC-420	NULL
to	NULL
remove	NULL
residual	NULL
nucleic	NULL
acids	NULL
,	NULL
and	NULL
the	NULL
flow-through	NULL
fraction	NULL
was	NULL
dialyzed	NULL
for	NULL
5	NULL
h	NULL
against	NULL
BC-100	NULL
using	NULL
a	NULL
10-12-kDa	NULL
cut-off	NULL
cellulose	NULL
membrane	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
centrifuged	NULL
in	NULL
an	NULL
Eppendorf	NULL
microcentrifuge	NULL
(	NULL
10,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
)	NULL
at	NULL
4	NULL
Â°C	NULL
following	NULL
dialysis	NULL
to	NULL
remove	NULL
insoluble	NULL
material	NULL
,	NULL
and	NULL
aliquots	NULL
of	NULL
the	NULL
supernatant	NULL
frozen	NULL
at	NULL
-80	NULL
Â°C	NULL
.	NULL

Nuclear	NULL
extract	NULL
protein	NULL
concentrations	NULL
were	NULL
determined	NULL
using	NULL
the	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
with	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
as	NULL
the	NULL
protein	NULL
standard	NULL
(	NULL
51	NULL
)	NULL
,	NULL
and	NULL
ranged	NULL
between	NULL
~5-15	NULL
mg/ml	NULL
.	NULL

*	NULL
R.	NULL
A.	NULL
Currie	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
18222	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-EMSA	NULL
assays	NULL
,	NULL
and	NULL
the	NULL
preparation	NULL
and	NULL
use	NULL
of	NULL
the	NULL
Ea	NULL
,	NULL
and	NULL
S-collagen	NULL
CCAAT-box	NULL
oligonucleo-tides	NULL
in	NULL
EMSA	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
*Â°P-Ea	NULL
DNA	NULL
oligomer	NULL
was	NULL
used	NULL
in	NULL
EMSA	NULL
to	NULL
normalize	NULL
nuclear	NULL
extracts	NULL
for	NULL
relative	NULL
NF-Y	NULL
CCAAT	NULL
DNA	NULL
binding	NULL
activities	NULL
for	NULL
use	NULL
in	NULL
comparative	NULL
chromatographic	NULL
analyses	NULL
.	NULL

In	NULL
EMSA	NULL
,	NULL
protein	NULL
fractions	NULL
were	NULL
mixed	NULL
with	NULL
~2	NULL
ug	NULL
of	NULL
the	NULL
nonspecific	NULL
DNA	NULL
competitor	NULL
,	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Bio-tech	NULL
)	NULL
,	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
~0.2	NULL
ng	NULL
of	NULL
*Â°P-labeled	NULL
DNA	NULL
oligonucleotide	NULL
probe	NULL
in	NULL
a	NULL
30-ul	NULL
binding	NULL
reaction	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
at	NULL
30	NULL
Â°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
then	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
non-denaturing	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
80:1	NULL
acrylamide/bisacrylamide	NULL
ratio	NULL
)	NULL
containing	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
50	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
1.0	NULL
mM	NULL
EDTA	NULL
(	NULL
0.5	NULL
X	NULL
TBE	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
electrophoresed	NULL
at	NULL
~150	NULL
V	NULL
for	NULL
1.5	NULL
h	NULL
following	NULL
pre-running	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
using	NULL
0.5	NULL
x	NULL
TBE	NULL
as	NULL
the	NULL
running	NULL
buffer	NULL
.	NULL

Dried	NULL
gels	NULL
were	NULL
exposed	NULL
to	NULL
XAR-5	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
)	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
(	NULL
DuPont	NULL
)	NULL
at	NULL
-80	NULL
Â°C	NULL
.	NULL

Chromatographic	NULL
Procedures-Anion	NULL
exchangers	NULL
,	NULL
Q*	NULL
Sepharose	NULL
,	NULL
DEAE-Sepharose	NULL
,	NULL
and	NULL
the	NULL
cation	NULL
exchanger	NULL
,	NULL
S~	NULL
Sepharose	NULL
,	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
specifications	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
equilibrated	NULL
in	NULL
BC-100	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
depleted	NULL
of	NULL
YAF	NULL
proteins	NULL
by	NULL
first	NULL
passing	NULL
extracts	NULL
over	NULL
DEAE-Sepharose	NULL
in	NULL
BC-420	NULL
,	NULL
followed	NULL
by	NULL
dialysis	NULL
against	NULL
several	NULL
changes	NULL
of	NULL
BC-420	NULL
over	NULL
an	NULL
8-h	NULL
period	NULL
using	NULL
a	NULL
Spectra/Por	NULL
6	NULL
(	NULL
25-kDa	NULL
cut-off	NULL
)	NULL
cellulose	NULL
membrane	NULL
(	NULL
Spectrum	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
extracts	NULL
were	NULL
dialyzed	NULL
against	NULL
BC-100	NULL
for	NULL
4	NULL
h	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
Â°C	NULL
,	NULL
following	NULL
centrifugation	NULL
to	NULL
remove	NULL
insoluble	NULL
material	NULL
.	NULL

The	NULL
NF-YA	NULL
subunit	NULL
was	NULL
prepared	NULL
from	NULL
YAF-depleted	NULL
nuclear	NULL
extracts	NULL
by	NULL
heating	NULL
nuclear	NULL
extracts	NULL
to	NULL
65	NULL
Â°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
placing	NULL
extracts	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
,	NULL
then	NULL
centrifuging	NULL
(	NULL
10,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
)	NULL
at	NULL
4	NULL
Â°C	NULL
in	NULL
an	NULL
Eppendorf	NULL
microcentrifuge	NULL
to	NULL
remove	NULL
insoluble	NULL
material	NULL
.	NULL

NF-YB	NULL
:	NULL
C	NULL
is	NULL
effectively	NULL
inactivated	NULL
following	NULL
this	NULL
heat	NULL
treatment	NULL
step	NULL
(	NULL
87	NULL
)	NULL
.	NULL

NF-YA	NULL
was	NULL
further	NULL
purified	NULL
by	NULL
passing	NULL
this	NULL
material	NULL
over	NULL
Q*	NULL
Sepharose	NULL
equilibrated	NULL
in	NULL
BC-100	NULL
,	NULL
and	NULL
collecting	NULL
the	NULL
flow-through	NULL
fraction	NULL
(	NULL
27	NULL
)	NULL
.	NULL

NF-YA	NULL
was	NULL
concentrated	NULL
using	NULL
Centricon	NULL
10	NULL
filtration	NULL
devices	NULL
,	NULL
stored	NULL
in	NULL
BC-100	NULL
at	NULL
-80	NULL
Â°C	NULL
,	NULL
and	NULL
used	NULL
to	NULL
complement	NULL
NF-YB	NULL
:	NULL
C	NULL
activity	NULL
in	NULL
recombination	NULL
experiments	NULL
.	NULL

NF-YB	NULL
:	NULL
C	NULL
subunits	NULL
were	NULL
isolated	NULL
following	NULL
Q*	NULL
and	NULL
S	NULL
%	NULL
Sepharose	NULL
chromatographic	NULL
separations	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
27	NULL
,	NULL
37	NULL
)	NULL
,	NULL
with	NULL
the	NULL
following	NULL
modifications	NULL
.	NULL

A20	NULL
and	NULL
MPC11	NULL
nuclear	NULL
extracts	NULL
,	NULL
depleted	NULL
of	NULL
YAF	NULL
proteins	NULL
as	NULL
described	NULL
above	NULL
,	NULL
were	NULL
applied	NULL
to	NULL
a	NULL
Q*	NULL
``	NULL
Sepharose	NULL
column	NULL
in	NULL
BC-	NULL
100	NULL
(	NULL
Tris-HCl	NULL
buffer	NULL
)	NULL
.	NULL

Following	NULL
extensive	NULL
washing	NULL
with	NULL
BC-100	NULL
,	NULL
NF-YB	NULL
:	NULL
C	NULL
was	NULL
step-eluted	NULL
using	NULL
BC-600	NULL
(	NULL
0.6	NULL
M	NULL
KC	NULL
]	NULL
,	NULL
and	NULL
dialyzed	NULL
against	NULL
BC-100	NULL
buffer	NULL
where	NULL
HEPES	NULL
had	NULL
been	NULL
substituted	NULL
for	NULL
Tris-	NULL
HCl	NULL
.	NULL

This	NULL
material	NULL
was	NULL
loaded	NULL
onto	NULL
a	NULL
S-	NULL
Sepharose	NULL
column	NULL
,	NULL
and	NULL
eluted	NULL
using	NULL
BC-100	NULL
(	NULL
HEPES	NULL
)	NULL
.	NULL

NF-YB	NULL
:	NULL
C	NULL
elutes	NULL
in	NULL
the	NULL
flow-through	NULL
fraction	NULL
,	NULL
whereas	NULL
residual	NULL
NF-YA	NULL
activity	NULL
binds	NULL
tightly	NULL
to	NULL
S~	NULL
Sepharose	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
NF-YB	NULL
:	NULL
C	NULL
fractions	NULL
in	NULL
each	NULL
case	NULL
were	NULL
concentrated	NULL
using	NULL
a	NULL
Centricon	NULL
10	NULL
filtration	NULL
device	NULL
,	NULL
and	NULL
the	NULL
buffer	NULL
was	NULL
exchanged	NULL
to	NULL
BC-100	NULL
(	NULL
Tris-HCl	NULL
)	NULL
.	NULL

NF-YB	NULL
:	NULL
C	NULL
fractions	NULL
were	NULL
stored	NULL
at	NULL
-80	NULL
Â°C	NULL
,	NULL
and	NULL
used	NULL
to	NULL
complement	NULL
the	NULL
NF-YA	NULL
subunit	NULL
in	NULL
recombination	NULL
experiments	NULL
.	NULL

The	NULL
elution	NULL
position	NULL
of	NULL
separated	NULL
NF-Y	NULL
subunits	NULL
was	NULL
identified	NULL
in	NULL
Q*	NULL
Sepharose	NULL
column	NULL
fractions	NULL
by	NULL
incubating	NULL
5	NULL
ul	NULL
of	NULL
each	NULL
column	NULL
fraction	NULL
with	NULL
10	NULL
ul	NULL
of	NULL
the	NULL
corresponding	NULL
complementing	NULL
partially	NULL
purified	NULL
YA	NULL
or	NULL
YB	NULL
:	NULL
C	NULL
subunit	NULL
fraction	NULL
in	NULL
a	NULL
80-ul	NULL
EMSA	NULL
reaction	NULL
.	NULL

In	NULL
dialysis	NULL
experiments	NULL
,	NULL
an	NULL
aliquot	NULL
of	NULL
an	NULL
A20	NULL
DEAE-Sepharose	NULL
column	NULL
flow-through	NULL
fraction	NULL
(	NULL
1.0	NULL
ml	NULL
;	NULL
~10	NULL
mg	NULL
of	NULL
protein	NULL
)	NULL
in	NULL
BC-420	NULL
was	NULL
dialyzed	NULL
separately	NULL
against	NULL
BC-420	NULL
using	NULL
a	NULL
10-12-kDa	NULL
cut-off	NULL
cellulose	NULL
membrane	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
against	NULL
BC-420	NULL
using	NULL
a	NULL
25-kDa	NULL
cut-off	NULL
cellulose	NULL
membrane	NULL
(	NULL
Spectrum	NULL
)	NULL
,	NULL
and	NULL
also	NULL
against	NULL
BC-100	NULL
using	NULL
a	NULL
25-kDa	NULL
cut-off	NULL
membrane	NULL
.	NULL

The	NULL
dialysis	NULL
buffers	NULL
were	NULL
changed	NULL
in	NULL
each	NULL
case	NULL
after	NULL
3	NULL
h	NULL
,	NULL
and	NULL
dialysis	NULL
continued	NULL
for	NULL
an	NULL
additional	NULL
3	NULL
h	NULL
at	NULL
4	NULL
Â°C	NULL
.	NULL

After	NULL
this	NULL
period	NULL
,	NULL
all	NULL
extracts	NULL
were	NULL
further	NULL
dialyzed	NULL
for	NULL
3	NULL
h	NULL
against	NULL
BC-100	NULL
.	NULL

Normalized	NULL
NF-Y	NULL
Ea	NULL
DNA	NULL
binding	NULL
activities	NULL
were	NULL
determined	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
.	NULL

To	NULL
prepare	NULL
NF-Y	NULL
from	NULL
nuclear	NULL
extract	NULL
fractions	NULL
depleted	NULL
of	NULL
YAF	NULL
activity	NULL
A20	NULL
or	NULL
MPC11	NULL
nuclear	NULL
extracts	NULL
were	NULL
first	NULL
passed	NULL
over	NULL
DEAE-Sepharose	NULL
in	NULL
BC-420	NULL
,	NULL
dialyzed	NULL
against	NULL
BC-420	NULL
for	NULL
8	NULL
h	NULL
using	NULL
a	NULL
Spectra/Por	NULL
6	NULL
(	NULL
25-kDa	NULL
cut-off	NULL
)	NULL
membrane	NULL
,	NULL
then	NULL
diluted	NULL
1:4	NULL
in	NULL
BC-0	NULL
buffer	NULL
.	NULL

This	NULL
material	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
heparin-agarose	NULL
(	NULL
Sigma	NULL
)	NULL
column	NULL
in	NULL
BC-100	NULL
,	NULL
and	NULL
the	NULL
column	NULL
was	NULL
developed	NULL
using	NULL
a	NULL
BC-KC	NULL
]	NULL
step	NULL
gradient	NULL
.	NULL

The	NULL
NF-Y	NULL
complex	NULL
eluted	NULL
in	NULL
the	NULL
0.42	NULL
M	NULL
KCl	NULL
step	NULL
was	NULL
dialyzed	NULL
against	NULL
BC-100	NULL
,	NULL
and	NULL
aliquots	NULL
stored	NULL
at	NULL
-80	NULL
Â°C	NULL
A20	NULL
NF-Y	NULL
derived	NULL
from	NULL
the	NULL
heparin-agarose	NULL
fraction	NULL
,	NULL
and	NULL
used	NULL
in	NULL
experiments	NULL
with	NULL
recombinant	NULL
PCA4	NULL
,	NULL
was	NULL
further	NULL
purified	NULL
using	NULL
a	NULL
CCAAT-box	NULL
DNA	NULL
affinity	NULL
column	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
89	NULL
)	NULL
.	NULL

Approximately	NULL
100	NULL
ug	NULL
of	NULL
the	NULL
affinity-purified	NULL
NF-Y	NULL
protein	NULL
fraction	NULL
was	NULL
recombined	NULL
with	NULL
either	NULL
~50	NULL
ug	NULL
of	NULL
purified	NULL
recombinant	NULL
PC4	NULL
,	NULL
or	NULL
purified	NULL
BSA	NULL
,	NULL
as	NULL
described	NULL
for	NULL
YAF	NULL
recombination	NULL
experiments	NULL
below	NULL
.	NULL

In	NULL
native	NULL
YAF	NULL
recombination	NULL
experiments	NULL
,	NULL
A20	NULL
YAFs	NULL
were	NULL
prepared	NULL
from	NULL
A20	NULL
nuclear	NULL
extracts	NULL
that	NULL
had	NULL
been	NULL
passed	NULL
over	NULL
DEAE-Sepharose	NULL
in	NULL
BC-420	NULL
.	NULL

The	NULL
heparin-agarose	NULL
A20	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
and	NULL
MPC11	NULL
NF-YA	NULL
:	NULL
NF-Y	NULL
-associated	NULL
Cofactors	NULL
in	NULL
Stage-specific	NULL
B-cells	NULL
B	NULL
:	NULL
C	NULL
fractions	NULL
were	NULL
compared	NULL
with	NULL
A20	NULL
nuclear	NULL
extracts	NULL
for	NULL
NF-Y	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

A20	NULL
nuclear	NULL
extracts	NULL
that	NULL
contained	NULL
~2-fold	NULL
greater	NULL
equivalents	NULL
of	NULL
CCAAT-box	NULL
DNA	NULL
binding	NULL
activity	NULL
were	NULL
used	NULL
to	NULL
prepare	NULL
the	NULL
A20	NULL
YAF	NULL
fraction	NULL
by	NULL
centrifuging	NULL
the	NULL
0.42	NULL
m	NULL
KCl	NULL
DEAE-Sepharose	NULL
fraction	NULL
through	NULL
a	NULL
Centricon	NULL
30	NULL
filtering	NULL
device	NULL
(	NULL
Amicon	NULL
)	NULL
in	NULL
a	NULL
DuPont	NULL
Sorvall	NULL
type	NULL
SM-24	NULL
rotor	NULL
(	NULL
7000	NULL
rpm	NULL
for	NULL
~8	NULL
h	NULL
at	NULL
4Â°C	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
89	NULL
)	NULL
.	NULL

The	NULL
individual	NULL
heparin-agarose	NULL
A20	NULL
,	NULL
or	NULL
MPC11	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
fraction	NULL
,	NULL
was	NULL
adjusted	NULL
to	NULL
0.42	NULL
M	NULL
KCl	NULL
,	NULL
recombined	NULL
with	NULL
the	NULL
Centricon	NULL
30	NULL
filtrate	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
.	NULL

This	NULL
material	NULL
was	NULL
then	NULL
dialyzed	NULL
against	NULL
BC-100	NULL
using	NULL
a	NULL
10-12-kDa	NULL
cut-off	NULL
cellulose	NULL
membrane	NULL
for	NULL
3	NULL
h	NULL
at	NULL
4	NULL
Â°C	NULL
to	NULL
permit	NULL
protein	NULL
reas-sociation	NULL
.	NULL

NF-Y	NULL
complex	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
in	NULL
these	NULL
recombined	NULL
fractions	NULL
was	NULL
determined	NULL
following	NULL
dialysis	NULL
using	NULL
EMSA	NULL
.	NULL

The	NULL
A20	NULL
YAF	NULL
fraction	NULL
,	NULL
as	NULL
prepared	NULL
using	NULL
Centricon	NULL
30	NULL
filtration	NULL
devices	NULL
,	NULL
was	NULL
depleted	NULL
of	NULL
protein	NULL
by	NULL
incubation	NULL
with	NULL
StrataClean	NULL
resin	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Silica	NULL
beads	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
the	NULL
depletion	NULL
procedure	NULL
was	NULL
repeated	NULL
.	NULL

This	NULL
depleted	NULL
YAF	NULL
fraction	NULL
was	NULL
recombined	NULL
with	NULL
A20	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
,	NULL
and	NULL
the	NULL
NF-Y	NULL
complex	NULL
was	NULL
tested	NULL
for	NULL
Q*	NULL
Sepharose	NULL
binding	NULL
using	NULL
EMSA	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Normalized	NULL
amounts	NULL
of	NULL
NF-Y	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
were	NULL
loaded	NULL
onto	NULL
ion	NULL
exchange	NULL
columns	NULL
,	NULL
and	NULL
developed	NULL
using	NULL
a	NULL
BC-KCl	NULL
step	NULL
gradient	NULL
(	NULL
0.1	NULL
,	NULL
0.3	NULL
,	NULL
0.6	NULL
,	NULL
and	NULL
1.0	NULL
M	NULL
KC	NULL
]	NULL
)	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
the	NULL
column	NULL
load	NULL
material	NULL
and	NULL
a	NULL
5-ul	NULL
aliquot	NULL
of	NULL
each	NULL
column	NULL
fraction	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
CCAAT-box	NULL
DNA	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
Ea	NULL
oligomer	NULL
probe	NULL
using	NULL
EMSA	NULL
.	NULL

Equivalent	NULL
film	NULL
exposures	NULL
were	NULL
obtained	NULL
for	NULL
each	NULL
chromatographic	NULL
analysis	NULL
in	NULL
order	NULL
to	NULL
directly	NULL
compare	NULL
the	NULL
relative	NULL
level	NULL
of	NULL
NF-Y	NULL
complex	NULL
binding	NULL
to	NULL
ion	NULL
exchange	NULL
materials	NULL
.	NULL

RESULTS	NULL
Anion	NULL
Exchange	NULL
Properties	NULL
of	NULL
the	NULL
NF-Y	NULL
Complex	NULL
in	NULL
Stage-specific	NULL
B	NULL
Lymphocyte	NULL
Cell	NULL
Lines-NF-Y	NULL
is	NULL
ubiquitously	NULL
expressed	NULL
in	NULL
mammalian	NULL
tissues	NULL
,	NULL
and	NULL
is	NULL
known	NULL
to	NULL
play	NULL
an	NULL
essential	NULL
functional	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
many	NULL
tissue-specific	NULL
(	NULL
MHC	NULL
class	NULL
II	NULL
,	NULL
collagen	NULL
Â«	NULL
2	NULL
(	NULL
I	NULL
)	NULL
,	NULL
lipoprotein	NULL
lipase	NULL
)	NULL
,	NULL
cell-cycle	NULL
regulated	NULL
(	NULL
cyclin	NULL
A	NULL
,	NULL
ede2	NULL
)	NULL
,	NULL
and	NULL
inducible	NULL
(	NULL
HMG-CoA	NULL
,	NULL
interleukin-4	NULL
)	NULL
eukaryotic	NULL
genes	NULL
;	NULL
however	NULL
,	NULL
the	NULL
underlying	NULL
transcriptional	NULL
mechanisms	NULL
that	NULL
depend	NULL
on	NULL
NF-Y	NULL
and	NULL
its	NULL
interaction	NULL
with	NULL
other	NULL
combinations	NULL
of	NULL
general	NULL
proximal-promoter	NULL
factors	NULL
(	NULL
eg	NULL
.	NULL

Oct-1	NULL
,	NULL
Spl	NULL
,	NULL
RFX	NULL
)	NULL
,	NULL
and	NULL
components	NULL
of	NULL
the	NULL
basic	NULL
RNA	NULL
polymerase	NULL
II	NULL
machinery	NULL
in	NULL
these	NULL
diverse	NULL
situations	NULL
are	NULL
largely	NULL
unknown	NULL
.	NULL

The	NULL
CCAAT-box	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
Hela	NULL
CP1	NULL
complex	NULL
in	NULL
Hela	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
,	NULL
the	NULL
HAP2/3	NULL
complex	NULL
in	NULL
S.	NULL
cerevisice	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
the	NULL
CBF	NULL
complex	NULL
in	NULL
rat	NULL
liver	NULL
and	NULL
NIHS3T3	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
were	NULL
initially	NULL
shown	NULL
to	NULL
be	NULL
lost	NULL
following	NULL
ion	NULL
exchange	NULL
chromatography	NULL
,	NULL
but	NULL
could	NULL
be	NULL
reconstituted	NULL
by	NULL
recombining	NULL
specific	NULL
column	NULL
fractions	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
CBF-A	NULL
(	NULL
NF-YB	NULL
)	NULL
fraction	NULL
was	NULL
shown	NULL
to	NULL
contain	NULL
an	NULL
additional	NULL
protein	NULL
component	NULL
,	NULL
CBF-C	NULL
(	NULL
NF-YC	NULL
)	NULL
,	NULL
which	NULL
associated	NULL
with	NULL
CBF-A	NULL
through	NULL
strong	NULL
hydrophobic	NULL
interactions	NULL
and	NULL
coeluted	NULL
as	NULL
a	NULL
heterodimer	NULL
through	NULL
these	NULL
ion	NULL
exchange	NULL
materials	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
cloning	NULL
of	NULL
the	NULL
HAP5	NULL
subunit	NULL
(	NULL
36	NULL
)	NULL
,	NULL
these	NULL
studies	NULL
demonstrated	NULL
that	NULL
three	NULL
unique	NULL
subunits	NULL
were	NULL
minimally	NULL
required	NULL
for	NULL
specific	NULL
CCAAT-box	NULL
DNA	NULL
recognition	NULL
.	NULL

In	NULL
an	NULL
effort	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
ubiquitous	NULL
NF-Y	NULL
complex	NULL
exhibits	NULL
differential	NULL
``	NULL
tissue-specific	NULL
``	NULL
biochemical	NULL
properties	NULL
,	NULL
the	NULL
ion	NULL
exchange	NULL
behavior	NULL
of	NULL
NF-Y	NULL
was	NULL
examined	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
stage-specific	NULL
B	NULL
lymphocyte	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
anion	NULL
exchange	NULL
properties	NULL
of	NULL
NF-Y	NULL
derived	NULL
from	NULL
the	NULL
mature	NULL
murine	NULL
B-cell	NULL
lymphoma	NULL
,	NULL
A20	NULL
,	NULL
were	NULL
compared	NULL
with	NULL
the	NULL
terminally	NULL
differentiated	NULL
murine	NULL
plasmacytoma	NULL
B-cell	NULL
line	NULL
,	NULL
MPC11	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
A20	NULL
NF-Y	NULL
complex	NULL
revealed	NULL
near	NULL
quantitative	NULL
recovery	NULL
of	NULL
Ea	NULL
CCAAT-box	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
0.6	NULL
m	NULL
KCl	NULL
step	NULL
fractions	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
MPC11	NULL
NF-Y	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
virtually	NULL
lost	NULL
following	NULL
Q*	NULL
Sepharose	NULL
analysis	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

A	NULL
low	NULL
level	NULL
of	NULL
residual	NULL
MPC11	NULL
NF-Y	NULL
was	NULL
consistently	NULL
observed	NULL
in	NULL
the	NULL
0.6	NULL
M	NULL
KC	NULL
]	NULL
step	NULL
fraction	NULL
(	NULL
panel	NULL
!	NULL

B	NULL
,	NULL
fraction	NULL
10	NULL
)	NULL
.	NULL

The	NULL
A20	NULL
and	NULL
MPC11	NULL
Ea	NULL
DNA	NULL
binding	NULL
activities	NULL
identified	NULL
in	NULL
the	NULL
0.6	NULL
1	NULL
KCI	NULL
step	NULL
fractions	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
bona	NULL
fide	NULL
NF-Y	NULL
complexes	NULL
,	NULL
respectively	NULL
,	NULL
using	NULL
a-NF-YB	NULL
antibodies	NULL
in	NULL
EMSA	NULL
upshift	NULL
assays	NULL
.	NULL
``	NULL

These	NULL
observations	NULL
have	NULL
been	NULL
ex	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
NF-Y	NULL
-associated	NULL
Cofactors	NULL
in	NULL
Stage-specific	NULL
B-cells	NULL
A	NULL
0.3	NULL
M	NULL
=_	NULL
0.6	NULL
M	NULL
__	NULL
1.0	NULL
M	NULL
|	NULL
I	NULL
I	NULL
NF-Y	NULL
_-	NULL
u	NULL
m	NULL
B	NULL
MPC	NULL
11	NULL
Nr-y	NULL
-	NULL
i	NULL
LIF	NULL
IDL	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
H1	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Anion	NULL
exchange	NULL
behavior	NULL
of	NULL
the	NULL
NF-Y	NULL
complex	NULL
derived	NULL
from	NULL
stage-specific	NULL
B	NULL
lymphocytes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
murine	NULL
mature	NULL
B-cell	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
A20	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
the	NULL
murine	NULL
plasmacytoma	NULL
cell	NULL
line	NULL
,	NULL
MPC11	NULL
(	NULL
B	NULL
)	NULL
,	NULL
were	NULL
compared	NULL
for	NULL
NF-Y	NULL
complex	NULL
binding	NULL
to	NULL
the	NULL
anion	NULL
exchanger	NULL
,	NULL
Q*	NULL
Sepharose	NULL
.	NULL

The	NULL
columns	NULL
were	NULL
developed	NULL
using	NULL
a	NULL
KC	NULL
]	NULL
step	NULL
gradient	NULL
,	NULL
and	NULL
each	NULL
fraction	NULL
was	NULL
assayed	NULL
for	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
using	NULL
EMSA	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
KC	NULL
]	NULL
step-gradient	NULL
are	NULL
shown	NULL
above	NULL
panel	NULL
A	NULL
,	NULL
and	NULL
the	NULL
position	NULL
of	NULL
the	NULL
NF-Y	NULL
complex	NULL
is	NULL
denoted	NULL
to	NULL
the	NULL
Zeft	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

Lane	NULL
L	NULL
,	NULL
column	NULL
load	NULL
material	NULL
;	NULL
lane	NULL
P	NULL
,	NULL
free	NULL
Â°Â°P-Ea	NULL
DNA	NULL
probe	NULL
;	NULL
lanes	NULL
1-17	NULL
,	NULL
Q*	NULL
Sepharose	NULL
column	NULL
fractions	NULL
.	NULL

tended	NULL
to	NULL
a	NULL
number	NULL
of	NULL
additional	NULL
murine	NULL
and	NULL
human	NULL
mature	NULL
B-cell	NULL
lines	NULL
(	NULL
e.g	NULL
.	NULL

CH27	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
Daudi	NULL
)	NULL
,	NULL
to	NULL
other	NULL
murine	NULL
plasmacytoma	NULL
B-cell	NULL
lines	NULL
(	NULL
e.g	NULL
.	NULL

S107	NULL
,	NULL
MOPC	NULL
315	NULL
,	NULL
and	NULL
P3X63Ag8	NULL
)	NULL
using	NULL
both	NULL
Q*	NULL
Sepharose	NULL
and	NULL
DEAE-Sepharose	NULL
.	NULL

In	NULL
these	NULL
cases	NULL
,	NULL
the	NULL
mature	NULL
B-cell	NULL
NF-Y	NULL
complex	NULL
was	NULL
observed	NULL
to	NULL
bind	NULL
to	NULL
Q*	NULL
and	NULL
DEAE-Sepharose	NULL
with	NULL
high	NULL
affinity	NULL
as	NULL
an	NULL
intact	NULL
multimeric	NULL
complex	NULL
,	NULL
whereas	NULL
the	NULL
plasma	NULL
B-cell	NULL
NF-Y	NULL
complex	NULL
separated	NULL
into	NULL
discrete	NULL
subunit	NULL
fractions	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NF-Y	NULL
derived	NULL
from	NULL
a	NULL
number	NULL
of	NULL
MHC	NULL
class	NULL
II_	NULL
cell	NULL
lines	NULL
(	NULL
e.g	NULL
.	NULL

Hela	NULL
,	NULL
3T38-L1	NULL
,	NULL
and	NULL
TAl	NULL
)	NULL
exhibit	NULL
identical	NULL
Q*	NULL
Sepharose	NULL
binding	NULL
behavior	NULL
as	NULL
observed	NULL
in	NULL
MPC11	NULL
cells	NULL
.	NULL
``	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
biochemical	NULL
properties	NULL
of	NULL
NF-Y	NULL
are	NULL
altered	NULL
during	NULL
B-cell	NULL
development	NULL
,	NULL
and	NULL
that	NULL
high	NULL
affinity	NULL
NF-Y	NULL
Q*	NULL
binding	NULL
correlates	NULL
with	NULL
activation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
mature	NULL
B-cells	NULL
,	NULL
and	NULL
loss	NULL
of	NULL
Q*	NULL
binding	NULL
correlates	NULL
with	NULL
suppression	NULL
of	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
in	NULL
terminally	NULL
differentiated	NULL
plasma	NULL
B-cells	NULL
.	NULL

In	NULL
order	NULL
to	NULL
locate	NULL
and	NULL
verify	NULL
the	NULL
identity	NULL
of	NULL
NF-Y	NULL
subunits	NULL
separated	NULL
during	NULL
Q*	NULL
analysis	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
individual	NULL
complementing	NULL
A20	NULL
and	NULL
MPC	NULL
11	NULL
NF-Y	NULL
subunits	NULL
were	NULL
prepared	NULL
and	NULL
used	NULL
in	NULL
recombination	NULL
EMSA	NULL
assays	NULL
.	NULL

NF-YA	NULL
and	NULL
NF-YB	NULL
:	NULL
C	NULL
fractions	NULL
were	NULL
added	NULL
individually	NULL
to	NULL
A20	NULL
and	NULL
MPC	NULL
11	NULL
Q*	NULL
fractions	NULL
,	NULL
and	NULL
tested	NULL
for	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
exogenous	NULL
A20	NULL
YB	NULL
:	NULL
C	NULL
activity	NULL
to	NULL
the	NULL
A20	NULL
Q*	NULL
fractions	NULL
identified	NULL
a	NULL
small	NULL
quantity	NULL
of	NULL
additional	NULL
A20	NULL
YA	NULL
activity	NULL
in	NULL
the	NULL
early	NULL
region	NULL
(	NULL
0.1	NULL
m	NULL
KCI	NULL
)	NULL
of	NULL
the	NULL
step	NULL
gradient	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
YA	NULL
subunit	NULL
activity	NULL
however	NULL
,	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
0.6	NULL
m	NULL
KCl	NULL
step	NULL
fraction	NULL
.	NULL

Addition	NULL
of	NULL
exogenous	NULL
A20	NULL
YA	NULL
activity	NULL
did	NULL
not	NULL
reveal	NULL
any	NULL
additional	NULL
A20	NULL
YB	NULL
:	NULL
C	NULL
activity	NULL
in	NULL
the	NULL
A20	NULL
Q*	NULL
fractions	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
analyses	NULL
suggest	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
A20	NULL
NF-YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
subunits	NULL
elute	NULL
together	NULL
from	NULL
Q*	NULL
Sepharose	NULL
as	NULL
an	NULL
intact	NULL
multisubunit	NULL
complex	NULL
in	NULL
the	NULL
0.6	NULL
m	NULL
KCI	NULL
fraction	NULL
.	NULL

Addition	NULL
of	NULL
exogenous	NULL
MPC11	NULL
YB	NULL
:	NULL
C	NULL
subunit	NULL
activity	NULL
to	NULL
the	NULL
MPC11	NULL
Q*	NULL
fractions	NULL
from	NULL
Fig	NULL
.	NULL

1	NULL
complemented	NULL
MPC11	NULL
YA	NULL
18223	NULL
A	NULL
0.3M	NULL
0.6M	NULL
1.0M	NULL
1	NULL
1	NULL
1	NULL
A20	NULL
YA	NULL
-+-	NULL
-~	NULL
<	NULL
--	NULL
-A20	NULL
YBC	NULL
++	NULL
4	NULL
4444	NULL
4b	NULL
t	NULL
t	NULL
4	NULL
t	NULL
4	NULL
+44	NULL
4+	NULL
NF-Y	NULL
-	NULL
.	NULL

U	NULL
is	NULL
NN	NULL
YB	NULL
:	NULL
C	NULL
C123	NULL
45678	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
B	NULL
A20	NULL
YBC	NULL
-p	NULL
A20	NULL
YA	NULL
NEY	NULL
-	NULL
'	NULL
tp	NULL
o	NULL
is	NULL
A	NULL
dui	NULL
ad	NULL
d	NULL
ad	NULL
d	NULL
dad	NULL
al	NULL
an	NULL
hl	NULL
ub	NULL
d	NULL
/	NULL
1111/44	NULL
AC	NULL
123456789	NULL
10	NULL
11	NULL
12131415	NULL
16	NULL
17	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Localization	NULL
of	NULL
additional	NULL
A20	NULL
NF-YA	NULL
subunit	NULL
activity	NULL
following	NULL
Q*	NULL
Sepharose	NULL
analysis	NULL
of	NULL
the	NULL
A20	NULL
NF-Y	NULL
complex	NULL
.	NULL

A20	NULL
NF-Y	NULL
Q*	NULL
Sepharose	NULL
fractions	NULL
from	NULL
Fig	NULL
.	NULL

14	NULL
were	NULL
assayed	NULL
for	NULL
additional	NULL
NF-YA	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
NF-YB	NULL
:	NULL
C	NULL
(	NULL
B	NULL
)	NULL
activities	NULL
through	NULL
addition	NULL
of	NULL
exogeneous	NULL
purified	NULL
complementing	NULL
native	NULL
A20	NULL
YB	NULL
:	NULL
C	NULL
or	NULL
YA	NULL
subunit	NULL
fractions	NULL
,	NULL
respectively	NULL
.	NULL

NF-Y	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
determined	NULL
using	NULL
EMSA	NULL
.	NULL

Complementing	NULL
subunit	NULL
activities	NULL
are	NULL
denoted	NULL
above	NULL
each	NULL
panel	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
KC	NULL
]	NULL
step	NULL
gradient	NULL
are	NULL
shown	NULL
above	NULL
A	NULL
,	NULL
and	NULL
the	NULL
position	NULL
of	NULL
the	NULL
NF-Y	NULL
complex	NULL
is	NULL
denoted	NULL
to	NULL
the	NULL
Zef	NULL
?	NULL

of	NULL
each	NULL
panel	NULL
.	NULL

In	NULL
A	NULL
,	NULL
lane	NULL
YB	NULL
:	NULL
C	NULL
denotes	NULL
the	NULL
YB	NULL
:	NULL
C	NULL
fraction	NULL
alone	NULL
;	NULL
lane	NULL
C	NULL
,	NULL
control	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
subunits	NULL
recombined	NULL
;	NULL
lanes	NULL
I-17	NULL
,	NULL
Q*	NULL
fractions	NULL
derived	NULL
from	NULL
A20	NULL
Q*	NULL
analysis	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

In	NULL
B	NULL
,	NULL
lane	NULL
A	NULL
denotes	NULL
YA	NULL
subunit	NULL
alone	NULL
;	NULL
lane	NULL
C	NULL
,	NULL
control	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
subunits	NULL
recombined	NULL
;	NULL
lames	NULL
1-17	NULL
,	NULL
Q*	NULL
fractions	NULL
derived	NULL
from	NULL
A20	NULL
Q*	NULL
analysis	NULL
in	NULL
Fig	NULL
.	NULL

14.	NULL
activity	NULL
,	NULL
which	NULL
had	NULL
separated	NULL
from	NULL
the	NULL
YB	NULL
:	NULL
C	NULL
subunits	NULL
during	NULL
application	NULL
of	NULL
the	NULL
KCl	NULL
gradient	NULL
and	NULL
was	NULL
located	NULL
in	NULL
the	NULL
low	NULL
salt	NULL
gradient	NULL
fractions	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

MPC11	NULL
YB	NULL
:	NULL
C	NULL
activity	NULL
was	NULL
identified	NULL
following	NULL
complementation	NULL
with	NULL
MPC11	NULL
YA	NULL
activity	NULL
only	NULL
in	NULL
the	NULL
0.6	NULL
M	NULL
KCl	NULL
step	NULL
fraction	NULL
of	NULL
the	NULL
gradient	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
demonstrate	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
NF-Y	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
MPC11	NULL
nuclear	NULL
extracts	NULL
following	NULL
Q*	NULL
Sepharose	NULL
chromatography	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
is	NULL
due	NULL
to	NULL
physical	NULL
separation	NULL
of	NULL
the	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
subunits	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
comparisons	NULL
suggest	NULL
that	NULL
the	NULL
biochemical	NULL
properties	NULL
of	NULL
the	NULL
NF-Y	NULL
complex	NULL
are	NULL
altered	NULL
in	NULL
a	NULL
stage-specific	NULL
manner	NULL
during	NULL
the	NULL
transition	NULL
from	NULL
a	NULL
mature	NULL
B-cell	NULL
to	NULL
a	NULL
plasma	NULL
B-cell	NULL
.	NULL

Ethidium	NULL
bromide	NULL
(	NULL
EtBr	NULL
)	NULL
is	NULL
a	NULL
compound	NULL
that	NULL
is	NULL
known	NULL
to	NULL
intercalate	NULL
between	NULL
duplex	NULL
DNA	NULL
strands	NULL
,	NULL
to	NULL
prevent	NULL
transcription	NULL
factors	NULL
from	NULL
binding	NULL
to	NULL
their	NULL
sequence-specific	NULL
elements	NULL
,	NULL
and	NULL
to	NULL
be	NULL
useful	NULL
in	NULL
assessing	NULL
if	NULL
associations	NULL
observed	NULL
between	NULL
a	NULL
protein	NULL
and	NULL
additional	NULL
putative	NULL
protein	NULL
cofactors	NULL
are	NULL
specific	NULL
,	NULL
and	NULL
not	NULL
due	NULL
to	NULL
cofactor	NULL
interaction	NULL
with	NULL
contaminating	NULL
nuclear	NULL
DNA	NULL
(	NULL
52-54	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
testing	NULL
the	NULL
effectiveness	NULL
of	NULL
EtBr	NULL
in	NULL
disrupting	NULL
A20	NULL
NF-Y	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

A20	NULL
nuclear	NULL
extracts	NULL
were	NULL
treated	NULL
in	NULL
control	NULL
experiments	NULL
with	NULL
increasing	NULL
EtBr	NULL
concentrations	NULL
,	NULL
and	NULL
tested	NULL
for	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
pane	NULL
!	NULL

A	NULL
)	NULL
.	NULL

EtBr	NULL
concentrations	NULL
of	NULL
50	NULL
or	NULL
100	NULL
ug/ml	NULL
essentially	NULL
inhibited	NULL
A20	NULL
NF-Y	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

A20	NULL
nuclear	NULL
extracts	NULL
were	NULL
made	NULL
50	NULL
ug/ml	NULL
in	NULL
EtBr	NULL
,	NULL
applied	NULL
to	NULL
a	NULL
Q*	NULL
column	NULL
equilibrated	NULL
in	NULL
the	NULL
same	NULL
EtBr	NULL
concentration	NULL
,	NULL
and	NULL
KCl-step	NULL
eluted	NULL
(	NULL
panel	NULL
!	NULL

B	NULL
)	NULL
.	NULL

A20	NULL
Q*	NULL
column	NULL
fractions	NULL
were	NULL
assayed	NULL
for	NULL
DNA-binding	NULL
by	NULL
first	NULL
reducing	NULL
the	NULL
[	NULL
EtBr	NULL
]	NULL
to	NULL
10	NULL
ug/ml	NULL
.	NULL

A20	NULL
NF-Y	NULL
was	NULL
quantita-tively	NULL
recovered	NULL
in	NULL
the	NULL
0.6	NULL
m	NULL
KCl	NULL
step	NULL
fraction	NULL
from	NULL
this	NULL
Q*	NULL
column	NULL
.	NULL

Peak	NULL
A20	NULL
NF-Y	NULL
DNA	NULL
binding	NULL
fractions	NULL
from	NULL
the	NULL
Q*	NULL
column	NULL
(	NULL
fractions	NULL
9	NULL
and	NULL
10	NULL
)	NULL
were	NULL
also	NULL
shown	NULL
to	NULL
be	NULL
sensitive	NULL
to	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
18224	NULL
A	NULL
ï¬fM	NULL
[	NULL
TM	NULL
Ll	NULL
'M	NULL
MPCIL	NULL
YA	NULL
+++	NULL
Â«	NULL
-	NULL
>	NULL
>	NULL
s	NULL
%	NULL
kok	NULL
s	NULL
sok	NULL
k	NULL
k	NULL
k	NULL
k	NULL
kom	NULL
MPCII	NULL
YB	NULL
:	NULL
C	NULL
-	NULL
++	NULL
+	NULL
+4	NULL
+	NULL
i+	NULL
t	NULL
i4	NULL
b	NULL
ob+	NULL
t	NULL
tb	NULL
+	NULL
#	NULL
NEY	NULL
-	NULL
wn	NULL
o	NULL
Â»	NULL
Mhas	NULL
b	NULL
Wid	NULL
#	NULL
W	NULL
int	NULL
i	NULL
)	NULL
PTÂ¥B.c	NULL
C	NULL
!	NULL

234	NULL
5	NULL
6	NULL
7	NULL
8	NULL
91011	NULL
1213	NULL
14	NULL
15	NULL
16	NULL
17	NULL
B	NULL
MPCII	NULL
YA	NULL
+	NULL
++	NULL
t+	NULL
t+	NULL
i+	NULL
i+	NULL
i+	NULL
i+	NULL
+4	NULL
+	NULL
+	NULL
MPC11	NULL
YB	NULL
:	NULL
-+	NULL
=	NULL
=	NULL
-	NULL
-	NULL
<	NULL
4	NULL
k	NULL
k	NULL
k	NULL
k	NULL
k	NULL
k	NULL
22	NULL
2k	NULL
4	NULL
NF-Y	NULL
-	NULL
ow	NULL
but	NULL
tal	NULL
bat	NULL
|	NULL
AC	NULL
12	NULL
3	NULL
4	NULL
567	NULL
8	NULL
910	NULL
11121314	NULL
15	NULL
16	NULL
17	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Identification	NULL
of	NULL
separated	NULL
MPC11	NULL
NF-Y	NULL
subunits	NULL
following	NULL
Q*	NULL
Sepharose	NULL
chromatography	NULL
.	NULL

MPC11	NULL
NF-Y	NULL
Q*	NULL
Sepharose	NULL
fractions	NULL
from	NULL
Fig	NULL
.	NULL

1B	NULL
were	NULL
assayed	NULL
for	NULL
YA	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
(	NULL
B	NULL
)	NULL
activities	NULL
through	NULL
addition	NULL
of	NULL
exogeneous	NULL
purified	NULL
complementing	NULL
native	NULL
MPC11	NULL
YB	NULL
:	NULL
C	NULL
or	NULL
YA	NULL
subunit	NULL
fractions	NULL
,	NULL
respectively	NULL
.	NULL

NF-Y	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
determined	NULL
using	NULL
EMSA	NULL
.	NULL

Complementing	NULL
subunit	NULL
activities	NULL
are	NULL
denoted	NULL
above	NULL
each	NULL
panel	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
KCl	NULL
step	NULL
gradient	NULL
are	NULL
shown	NULL
above	NULL
A	NULL
,	NULL
and	NULL
the	NULL
position	NULL
of	NULL
the	NULL
NF-Y	NULL
complex	NULL
is	NULL
denoted	NULL
to	NULL
the	NULL
left	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

In	NULL
A	NULL
,	NULL
lane	NULL
P	NULL
denotes	NULL
free	NULL
*Â°P-Ea	NULL
DNA	NULL
probe	NULL
;	NULL
lane	NULL
YB	NULL
:	NULL
C	NULL
denotes	NULL
the	NULL
YB	NULL
:	NULL
C	NULL
fraction	NULL
alone	NULL
;	NULL
lane	NULL
C	NULL
,	NULL
control	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
subunits	NULL
recombined	NULL
;	NULL
lanes	NULL
1-17	NULL
,	NULL
Q*	NULL
fractions	NULL
derived	NULL
from	NULL
MPC11	NULL
Q*	NULL
analysis	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

In	NULL
B	NULL
,	NULL
lane	NULL
A	NULL
,	NULL
YA	NULL
subunit	NULL
alone	NULL
;	NULL
lane	NULL
C	NULL
,	NULL
control	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
subunits	NULL
recombined	NULL
;	NULL
lames	NULL
1-17	NULL
,	NULL
Q*	NULL
fractions	NULL
derived	NULL
from	NULL
MPC11	NULL
Q*	NULL
analysis	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

increasing	NULL
[	NULL
EtBr	NULL
]	NULL
,	NULL
as	NULL
an	NULL
[	NULL
EtBr	NULL
]	NULL
of	NULL
50	NULL
and	NULL
100	NULL
ug/ml	NULL
inhibited	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
panel	NULL
C	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
A20	NULL
NF-Y	NULL
complex	NULL
interacts	NULL
with	NULL
Q*	NULL
Sepharose	NULL
anionic	NULL
groups	NULL
directly	NULL
,	NULL
and	NULL
not	NULL
through	NULL
nonspecific	NULL
DNA	NULL
,	NULL
or	NULL
DNA-protein	NULL
interactions	NULL
.	NULL

Further	NULL
support	NULL
for	NULL
this	NULL
conclusion	NULL
was	NULL
reached	NULL
by	NULL
treating	NULL
A20	NULL
nuclear	NULL
extracts	NULL
with	NULL
high	NULL
concentrations	NULL
(	NULL
0.1	NULL
unit/ul	NULL
)	NULL
of	NULL
micrococcal	NULL
nuclease	NULL
or	NULL
DNase	NULL
I	NULL
prior	NULL
to	NULL
Q*	NULL
column	NULL
analysis	NULL
.	NULL

Both	NULL
treatments	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
A20	NULL
NF-Y	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
suggesting	NULL
that	NULL
contaminating	NULL
DNA	NULL
and/or	NULL
nonspecific	NULL
DNA-protein	NULL
cofactor	NULL
interactions	NULL
are	NULL
not	NULL
responsible	NULL
for	NULL
A20	NULL
NF-Y	NULL
binding	NULL
to	NULL
anion	NULL
exchange	NULL
materials	NULL
.	NULL
``	NULL

High	NULL
Affinity	NULL
Binding	NULL
of	NULL
A20	NULL
NF-Y	NULL
to	NULL
Q*	NULL
Sepharose	NULL
Is	NULL
Dependent	NULL
on	NULL
the	NULL
Mature	NULL
B-cell	NULL
YAF	NULL
Fraction-To	NULL
test	NULL
the	NULL
concept	NULL
that	NULL
the	NULL
NF-Y	NULL
complex	NULL
in	NULL
mature	NULL
B-cells	NULL
is	NULL
associated	NULL
with	NULL
one	NULL
,	NULL
or	NULL
more	NULL
,	NULL
small	NULL
molecular	NULL
mass	NULL
polypeptides	NULL
,	NULL
in	NULL
comparison	NULL
to	NULL
the	NULL
known	NULL
YA	NULL
(	NULL
~42	NULL
kDa	NULL
)	NULL
,	NULL
YB	NULL
(	NULL
~36	NULL
kDa	NULL
)	NULL
,	NULL
and	NULL
YC	NULL
(	NULL
~40	NULL
kDa	NULL
)	NULL
subunits	NULL
,	NULL
a	NULL
series	NULL
of	NULL
dialysis	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
cellulose	NULL
membranes	NULL
of	NULL
defined	NULL
molecular	NULL
mass	NULL
cut-off	NULL
and	NULL
under	NULL
specific	NULL
KCl	NULL
concentration	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

A20	NULL
nuclear	NULL
extracts	NULL
were	NULL
first	NULL
dialyzed	NULL
against	NULL
BC-420	NULL
using	NULL
a	NULL
10-12-kDa	NULL
cut-off	NULL
cellulose	NULL
membrane	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
,	NULL
a	NULL
25-kDa	NULL
cut-off	NULL
cellulose	NULL
membrane	NULL
(	NULL
panel	NULL
!	NULL

B	NULL
)	NULL
,	NULL
and	NULL
against	NULL
BC-100	NULL
using	NULL
a	NULL
25-kDa	NULL
cut-off	NULL
cellulose	NULL
membrane	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
,	NULL
then	NULL
extracts	NULL
were	NULL
dialyzed	NULL
further	NULL
against	NULL
BC-100	NULL
in	NULL
each	NULL
case	NULL
.	NULL

The	NULL
A20	NULL
NF-Y	NULL
complex	NULL
was	NULL
tested	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
retain	NULL
or	NULL
lose	NULL
binding	NULL
affinity	NULL
for	NULL
Q*	NULL
Sepharose	NULL
following	NULL
dialysis	NULL
under	NULL
these	NULL
experimental	NULL
conditions	NULL
.	NULL

These	NULL
analyses	NULL
suggested	NULL
that	NULL
,	NULL
under	NULL
conditions	NULL
of	NULL
elevated	NULL
[	NULL
KCI	NULL
]	NULL
and	NULL
using	NULL
a	NULL
25-kDa	NULL
molecular	NULL
mass	NULL
cut-off	NULL
membrane	NULL
,	NULL
the	NULL
activity	NULL
associated	NULL
with	NULL
A20	NULL
NF-Y	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
dissociated	NULL
from	NULL
the	NULL
NF-Y	NULL
com	NULL
NF-Y	NULL
-associated	NULL
Cofactors	NULL
in	NULL
Stage-specific	NULL
B-cells	NULL
plex	NULL
and	NULL
was	NULL
lost	NULL
during	NULL
dialysis	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

Control	NULL
experiments	NULL
showed	NULL
that	NULL
the	NULL
[	NULL
KCI	NULL
]	NULL
and	NULL
dialysis	NULL
membrane	NULL
cut-off	NULL
size	NULL
were	NULL
critical	NULL
in	NULL
separating	NULL
this	NULL
activity	NULL
away	NULL
from	NULL
the	NULL
NF-Y	NULL
complex	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
lower	NULL
KCI	NULL
concentrations	NULL
of	NULL
0.1	NULL
M	NULL
were	NULL
insufficient	NULL
in	NULL
facilitating	NULL
dissociation	NULL
of	NULL
this	NULL
activity	NULL
using	NULL
a	NULL
25-kDa	NULL
cut-off	NULL
membrane	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
activity	NULL
associated	NULL
with	NULL
A20	NULL
NF-Y	NULL
Q*	NULL
binding	NULL
has	NULL
a	NULL
nominal	NULL
molecular	NULL
mass	NULL
between	NULL
10	NULL
and	NULL
25	NULL
kDa	NULL
,	NULL
and	NULL
can	NULL
be	NULL
physically	NULL
separated	NULL
from	NULL
the	NULL
NF-Y	NULL
A	NULL
:	NULL
B	NULL
:	NULL
C	NULL
subunit	NULL
complex	NULL
using	NULL
0.42	NULL
m	NULL
KCL	NULL
.	NULL

This	NULL
operationally	NULL
defined	NULL
activity	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
YAF	NULL
fraction	NULL
.	NULL

Subunit	NULL
recombination	NULL
assays	NULL
using	NULL
the	NULL
Q*	NULL
fractions	NULL
in	NULL
panel	NULL
B	NULL
and	NULL
exogenous	NULL
complementing	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
subunits	NULL
demonstrate	NULL
that	NULL
the	NULL
A20	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
activities	NULL
derived	NULL
from	NULL
dialyzed	NULL
A20	NULL
extracts	NULL
elute	NULL
in	NULL
a	NULL
manner	NULL
identical	NULL
to	NULL
MPC11	NULL
NF-Y	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.2	NULL
Ultrafiltration	NULL
has	NULL
been	NULL
used	NULL
previously	NULL
as	NULL
a	NULL
method	NULL
for	NULL
preparing	NULL
active	NULL
YAF	NULL
fractions	NULL
,	NULL
and	NULL
dialysis	NULL
using	NULL
a	NULL
25-kDa	NULL
cut-off	NULL
membrane	NULL
under	NULL
these	NULL
same	NULL
conditions	NULL
has	NULL
been	NULL
used	NULL
as	NULL
a	NULL
method	NULL
to	NULL
prepare	NULL
nuclear	NULL
extracts	NULL
depleted	NULL
of	NULL
YAF	NULL
activity	NULL
(	NULL
39	NULL
)	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
an	NULL
A20	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
fraction	NULL
depleted	NULL
of	NULL
YAF	NULL
activity	NULL
failed	NULL
to	NULL
bind	NULL
to	NULL
Q*	NULL
Sepharose	NULL
as	NULL
an	NULL
intact	NULL
heterotrimeric	NULL
complex	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

Recombination	NULL
of	NULL
the	NULL
A20	NULL
YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
fraction	NULL
with	NULL
the	NULL
separated	NULL
A20	NULL
YAF	NULL
fraction	NULL
,	NULL
however	NULL
,	NULL
fully	NULL
restored	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
A20	NULL
YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
complex	NULL
to	NULL
bind	NULL
to	NULL
Q*	NULL
Sepharose	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
prior	NULL
treatment	NULL
of	NULL
the	NULL
A20	NULL
YAF	NULL
fraction	NULL
with	NULL
DNase	NULL
I	NULL
or	NULL
micrococcal	NULL
nuclease	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
its	NULL
ability	NULL
to	NULL
confer	NULL
Q*	NULL
binding	NULL
to	NULL
A20	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C.2	NULL
Treatment	NULL
of	NULL
the	NULL
A20	NULL
YAF	NULL
fraction	NULL
with	NULL
protein	NULL
depleting	NULL
silica	NULL
beads	NULL
(	NULL
StrataClean	NULL
resin	NULL
)	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
restore	NULL
the	NULL
Q*	NULL
binding	NULL
phenotype	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
.	NULL

The	NULL
MPC11	NULL
NF-Y	NULL
subunits	NULL
were	NULL
shown	NULL
previously	NULL
to	NULL
separate	NULL
following	NULL
Q*	NULL
Sepharose	NULL
analysis	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
3	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
NF-Y	NULL
in	NULL
a	NULL
class	NULL
II~	NULL
plasmacytoma	NULL
B-cell	NULL
line	NULL
differs	NULL
in	NULL
biochemical	NULL
properties	NULL
from	NULL
the	NULL
NF-Y	NULL
complex	NULL
in	NULL
mature	NULL
B-cell	NULL
class	NULL
II*	NULL
lymphocytes	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
transfer	NULL
the	NULL
A20	NULL
YAF-dependent	NULL
Q*	NULL
phenotype	NULL
to	NULL
a	NULL
class	NULL
II_	NULL
NF-Y	NULL
complex	NULL
was	NULL
tested	NULL
by	NULL
recombining	NULL
MPC11	NULL
NF-Y	NULL
depleted	NULL
of	NULL
MPC	NULL
11	NULL
YAF	NULL
proteins	NULL
with	NULL
the	NULL
isolated	NULL
A20	NULL
YAF	NULL
fraction	NULL
,	NULL
and	NULL
assaying	NULL
for	NULL
high	NULL
affinity	NULL
NF-Y	NULL
Q*	NULL
binding	NULL
(	NULL
panel	NULL
D	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
Q*	NULL
Sepharose	NULL
was	NULL
successfully	NULL
transferred	NULL
to	NULL
MPC11	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
by	NULL
the	NULL
A20	NULL
YAF	NULL
fraction	NULL
,	NULL
and	NULL
the	NULL
MPC	NULL
11	NULL
NF-Y	NULL
elution	NULL
profile	NULL
was	NULL
identical	NULL
to	NULL
A20	NULL
NF-Y	NULL
recombined	NULL
with	NULL
the	NULL
A20	NULL
YAF	NULL
fraction	NULL
(	NULL
compare	NULL
panels	NULL
B	NULL
and	NULL
D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
further	NULL
suggest	NULL
that	NULL
the	NULL
A20	NULL
YAF	NULL
fraction	NULL
contains	NULL
an	NULL
activity	NULL
capable	NULL
of	NULL
conferring	NULL
high	NULL
affinity	NULL
Q*	NULL
binding	NULL
to	NULL
NF-Y	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
partially	NULL
purified	NULL
A20	NULL
YA	NULL
subunit	NULL
derived	NULL
from	NULL
A20	NULL
nuclear	NULL
extracts	NULL
has	NULL
been	NULL
recombined	NULL
with	NULL
a	NULL
partially	NULL
purified	NULL
Hela	NULL
YB	NULL
:	NULL
C	NULL
subunit	NULL
fraction	NULL
derived	NULL
from	NULL
this	NULL
class	NULL
II~	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
Q*	NULL
binding	NULL
.	NULL

Recombination	NULL
of	NULL
this	NULL
A20	NULL
YA	NULL
fraction	NULL
with	NULL
Hela	NULL
YB	NULL
:	NULL
C	NULL
restores	NULL
Ea	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
but	NULL
this	NULL
NF-Y	NULL
complex	NULL
fails	NULL
to	NULL
bind	NULL
to	NULL
Q*	NULL
Sepharose	NULL
as	NULL
an	NULL
intact	NULL
complex	NULL
.	NULL
``	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
Q*	NULL
Sepharose	NULL
is	NULL
not	NULL
contained	NULL
in	NULL
the	NULL
A20	NULL
YA	NULL
fraction	NULL
,	NULL
and	NULL
furthermore	NULL
suggests	NULL
that	NULL
A20	NULL
YA	NULL
itself	NULL
is	NULL
not	NULL
the	NULL
activity	NULL
responsible	NULL
for	NULL
high	NULL
affinity	NULL
Q*	NULL
binding	NULL
in	NULL
the	NULL
A20	NULL
NF-Y	NULL
complex	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
separate	NULL
this	NULL
activity	NULL
from	NULL
A20	NULL
NF-Y	NULL
,	NULL
and	NULL
to	NULL
successfully	NULL
recombine	NULL
the	NULL
YAF	NULL
fraction	NULL
with	NULL
the	NULL
depleted	NULL
A20	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
complex	NULL
,	NULL
which	NULL
itself	NULL
fails	NULL
to	NULL
bind	NULL
to	NULL
Q*	NULL
columns	NULL
,	NULL
represents	NULL
a	NULL
major	NULL
step	NULL
in	NULL
efforts	NULL
to	NULL
characterize	NULL
the	NULL
functional	NULL
properties	NULL
of	NULL
the	NULL
NF-Y-associated	NULL
cofactors	NULL
in	NULL
vitro	NULL
.	NULL

Transfer	NULL
of	NULL
A20	NULL
YAF	NULL
activity	NULL
to	NULL
the	NULL
MPC	NULL
11	NULL
NF-Y	NULL
complex	NULL
suggests	NULL
that	NULL
loss	NULL
of	NULL
YAF	NULL
functional	NULL
activity	NULL
in	NULL
the	NULL
NF-Y	NULL
complex	NULL
of	NULL
terminally	NULL
differentiated	NULL
B-cells	NULL
may	NULL
represent	NULL
a	NULL
critical	NULL
step	NULL
in	NULL
NF-Y	NULL
modulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
during	NULL
B-cell	NULL
development	NULL
.	NULL

Physical	NULL
Interaction	NULL
between	NULL
NF-YA	NULL
(	NULL
DBD	NULL
)	NULL
and	NULL
PC4-The	NULL
transcriptional	NULL
cofactor	NULL
,	NULL
PC4	NULL
,	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
compo-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
NF-Y	NULL
-associated	NULL
Cofactors	NULL
in	NULL
Stage-specific	NULL
B-cells	NULL
A	NULL
B	NULL
[	NULL
EtBr	NULL
]	NULL
NF-Y	NULL
PC	NULL
1	NULL
23	NULL
4	NULL
Wg	NULL
.	NULL

18225	NULL
C	NULL
__	NULL
r-Ft	NULL
10-7	NULL
_-	NULL
]	NULL
_-lk	NULL
nr-	NULL
vy	NULL
-	NULL
Wh	NULL
PoC	NULL
2	NULL
30	NULL
4	NULL
%	NULL
5	NULL
6	NULL
7	NULL
80	NULL
9	NULL
10	NULL
i1	NULL
12	NULL
P3	NULL
d4	NULL
is	NULL
is	NULL
I7	NULL
C1	NULL
r	NULL
3	NULL
4	NULL
C	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Analysis	NULL
of	NULL
A20	NULL
NF-Y	NULL
binding	NULL
to	NULL
the	NULL
Ea	NULL
DNA	NULL
oligomer	NULL
and	NULL
to	NULL
Q*	NULL
Sepharose	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ethidium	NULL
bromide	NULL
.	NULL

In	NULL
A	NULL
,	NULL
A20	NULL
nuclear	NULL
extracts	NULL
were	NULL
tested	NULL
for	NULL
NF-Y	NULL
binding	NULL
to	NULL
the	NULL
Ea	NULL
DNA	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
ethidium	NULL
bromide	NULL
.	NULL

In	NULL
B	NULL
,	NULL
A20	NULL
NF-Y	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
was	NULL
analyzed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
ug/ml	NULL
ethidium	NULL
bromide	NULL
.	NULL

The	NULL
Q*	NULL
column	NULL
fractionation	NULL
and	NULL
assay	NULL
conditions	NULL
were	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
and	NULL
the	NULL
BC-KCl	NULL
buffers	NULL
contained	NULL
50	NULL
pg/ml	NULL
ethidium	NULL
bromide	NULL
.	NULL

EMSA	NULL
of	NULL
these	NULL
Q*	NULL
fractions	NULL
(	NULL
B	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
diluting	NULL
the	NULL
ethidium	NULL
bromide	NULL
concentration	NULL
to	NULL
10	NULL
ug/ml	NULL
.	NULL

In	NULL
C	NULL
,	NULL
A20	NULL
NF-Y	NULL
peak	NULL
Q*	NULL
fractions	NULL
(	NULL
B	NULL
;	NULL
fractions	NULL
9	NULL
and	NULL
10	NULL
)	NULL
were	NULL
tested	NULL
for	NULL
inhibition	NULL
of	NULL
Ea	NULL
DNA	NULL
binding	NULL
by	NULL
ethidium	NULL
bromide	NULL
.	NULL

In	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lane	NULL
P	NULL
,	NULL
free	NULL
Â°Â°P-Ea	NULL
probe	NULL
.	NULL

In	NULL
A	NULL
and	NULL
C	NULL
,	NULL
lane	NULL
C	NULL
,	NULL
control	NULL
NF-Y	NULL
Ea	NULL
binding	NULL
activity	NULL
.	NULL

In	NULL
A	NULL
and	NULL
C	NULL
,	NULL
the	NULL
ethidium	NULL
bromide	NULL
concentrations	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
lane	NULL
C	NULL
,	NULL
0	NULL
ug/ml	NULL
;	NULL
lane	NULL
1	NULL
,	NULL
10	NULL
ug/ml	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
25	NULL
ug/ml	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
50	NULL
ug/ml	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
100	NULL
ug/ml	NULL
.	NULL

In	NULL
B	NULL
,	NULL
lanes	NULL
1-17	NULL
,	NULL
A20	NULL
Q*	NULL
Sepharose	NULL
column	NULL
fractions	NULL
.	NULL

A	NULL
0.3	NULL
M	NULL
0.6	NULL
M	NULL
1.0	NULL
M	NULL
|	NULL
A20	NULL
L	NULL
NF-Y	NULL
A20	NULL
NF-Y	NULL
-	NULL
i	NULL
Lol	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
%	NULL
9	NULL
10	NULL
111213	NULL
14	NULL
15	NULL
16	NULL
17	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
A20	NULL
NF-Y	NULL
complex	NULL
anion	NULL
exchange	NULL
binding	NULL
properties	NULL
following	NULL
dialysis	NULL
.	NULL

A20	NULL
nuclear	NULL
extracts	NULL
were	NULL
dialyzed	NULL
against	NULL
BC-420	NULL
using	NULL
a	NULL
10-12-kDa	NULL
cut-off	NULL
cellulose	NULL
membrane	NULL
(	NULL
A	NULL
)	NULL
,	NULL
a	NULL
25-kDa	NULL
cut-off	NULL
cellulose	NULL
membrane	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
against	NULL
BC-100	NULL
using	NULL
a	NULL
25-kDa	NULL
cut-off	NULL
cellulose	NULL
membrane	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
dialyzed	NULL
further	NULL
against	NULL
BC-100	NULL
in	NULL
each	NULL
case	NULL
,	NULL
and	NULL
tested	NULL
for	NULL
NF-Y	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
KC	NULL
]	NULL
step-gradient	NULL
are	NULL
shown	NULL
above	NULL
A	NULL
,	NULL
and	NULL
the	NULL
position	NULL
of	NULL
the	NULL
NF-Y	NULL
complex	NULL
is	NULL
denoted	NULL
to	NULL
the	NULL
left	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

nent	NULL
in	NULL
isolated	NULL
YAF	NULL
fractions	NULL
using	NULL
Western	NULL
blot	NULL
assays	NULL
,	NULL
``	NULL
and	NULL
was	NULL
shown	NULL
to	NULL
interact	NULL
in	NULL
vitro	NULL
with	NULL
NF-Y	NULL
through	NULL
the	NULL
highly	NULL
conserved	NULL
DBD	NULL
element	NULL
contained	NULL
in	NULL
the	NULL
YA	NULL
subunit	NULL
using	NULL
Far	NULL
Western	NULL
assays	NULL
in	NULL
a	NULL
previous	NULL
study	NULL
(	NULL
39	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
possibility	NULL
that	NULL
PC4	NULL
was	NULL
the	NULL
YAF	NULL
protein	NULL
that	NULL
alone	NULL
conferred	NULL
high	NULL
affinity	NULL
Q*	NULL
binding	NULL
to	NULL
NF-Y	NULL
,	NULL
affinity-purified	NULL
A20	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
derived	NULL
from	NULL
YAF-depleted	NULL
nuclear	NULL
extracts	NULL
was	NULL
recombined	NULL
with	NULL
purified	NULL
recombinant	NULL
PC4	NULL
and	NULL
assayed	NULL
for	NULL
Q*	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

PC4	NULL
was	NULL
observed	NULL
to	NULL
specifically	NULL
confer	NULL
to	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
Q*	NULL
Sepharose	NULL
as	NULL
an	NULL
intact	NULL
trimeric	NULL
complex	NULL
with	NULL
elution	NULL
properties	NULL
that	NULL
were	NULL
identical	NULL
to	NULL
the	NULL
NF-Y	NULL
complex	NULL
derived	NULL
from	NULL
unfractionated	NULL
mature	NULL
B-cell	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
and	NULL
to	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
recombined	NULL
with	NULL
the	NULL
mature	NULL
B-cell	NULL
YAF	NULL
fraction	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
B	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Recombinant	NULL
PC4	NULL
was	NULL
also	NULL
observed	NULL
to	NULL
specifically	NULL
stabilize	NULL
the	NULL
interaction	NULL
of	NULL
affinity-purified	NULL
NF-Y	NULL
binding	NULL
to	NULL
several	NULL
known	NULL
CCAAT-box	NULL
elements	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
PC4	NULL
may	NULL
stabilize	NULL
NF-YA	NULL
interactions	NULL
with	NULL
the	NULL
YB	NULL
:	NULL
C	NULL
heterodimer	NULL
and	NULL
as	NULL
a	NULL
result	NULL
may	NULL
stabilize	NULL
overall	NULL
NF-Y	NULL
interactions	NULL
with	NULL
CCAAT-box	NULL
DNA	NULL
motifs	NULL
.	NULL

To	NULL
define	NULL
the	NULL
region	NULL
in	NULL
PC4	NULL
responsible	NULL
for	NULL
interaction	NULL
with	NULL
NF-Y	NULL
,	NULL
Â°Â°P-YA	NULL
(	NULL
DBD	NULL
)	NULL
was	NULL
used	NULL
to	NULL
test	NULL
several	NULL
PC4	NULL
deletion	NULL
mutants	NULL
,	NULL
and	NULL
control	NULL
GST	NULL
fusion	NULL
proteins	NULL
,	NULL
in	NULL
a	NULL
glutathione-agarose	NULL
bead	NULL
pull-down	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

94	NULL
)	NULL
.	NULL

YA	NULL
(	NULL
DBD	NULL
)	NULL
was	NULL
observed	NULL
to	NULL
stably	NULL
interact	NULL
with	NULL
full-length	NULL
PC4	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
and	NULL
with	NULL
a	NULL
PC4	NULL
mutant	NULL
that	NULL
lacks	NULL
both	NULL
the	NULL
N-terminal	NULL
serine-rich	NULL
phosphorylation	NULL
region	NULL
and	NULL
the	NULL
region	NULL
responsible	NULL
for	NULL
binding	NULL
to	NULL
double-stranded	NULL
DNA	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
.	NULL

YA	NULL
(	NULL
DBD	NULL
)	NULL
did	NULL
not	NULL
interact	NULL
with	NULL
a	NULL
C-terminal	NULL
PC4	NULL
mutant	NULL
that	NULL
lacked	NULL
the	NULL
extreme	NULL
37	NULL
amino	NULL
acids	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
that	NULL
contained	NULL
these	NULL
37	NULL
amino	NULL
acids	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
the	NULL
general	NULL
transcription	NULL
repressor	NULL
,	NULL
Drl	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
interacts	NULL
with	NULL
the	NULL
C-terminal	NULL
region	NULL
in	NULL
PC4	NULL
,	NULL
and	NULL
maps	NULL
the	NULL
interaction	NULL
site	NULL
in	NULL
PC4	NULL
near	NULL
amino	NULL
acid	NULL
90	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
phosphorylated	NULL
PC4	NULL
retains	NULL
the	NULL
ability	NULL
to	NULL
specifically	NULL
interact	NULL
with	NULL
NF-Y	NULL
,	NULL
PC4	NULL
was	NULL
Â°Â°P-labeled	NULL
with	NULL
CKII	NULL
and	NULL
HMK	NULL
and	NULL
tested	NULL
in	NULL
the	NULL
glutathione-agarose	NULL
pull-down	NULL
assay	NULL
using	NULL
the	NULL
NF-Y	NULL
complex	NULL
,	NULL
several	NULL
NF-YA	NULL
mutants	NULL
,	NULL
and	NULL
other	NULL
control	NULL
GST	NULL
fusion	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

*Â°P-PC4	NULL
(	NULL
CKII	NULL
)	NULL
,	NULL
as	NULL
phosphorylated	NULL
by	NULL
CKII	NULL
,	NULL
was	NULL
observed	NULL
to	NULL
stably	NULL
interact	NULL
with	NULL
the	NULL
NF-Y	NULL
complex	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
full-length	NULL
YA	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
,	NULL
TFIIB	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
and	NULL
the	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
homolog	NULL
from	NULL
S.	NULL
cerevisice	NULL
,	NULL
HAP2	NULL
(	NULL
DBD	NULL
)	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

GST-YA	NULL
(	NULL
ADBD	NULL
)	NULL
,	NULL
which	NULL
lacked	NULL
the	NULL
DBD	NULL
element	NULL
,	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
*Â°P-PC4	NULL
(	NULL
CKII	NULL
)	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
as	NULL
did	NULL
GST-Drl	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
.	NULL

Â°Â°P-PC4	NULL
(	NULL
HMK	NULL
)	NULL
,	NULL
as	NULL
phosphorylated	NULL
by	NULL
HMK	NULL
,	NULL
was	NULL
observed	NULL
to	NULL
stably	NULL
interact	NULL
with	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
(	NULL
Zane	NULL
12	NULL
)	NULL
,	NULL
and	NULL
a	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
mutant	NULL
that	NULL
lacked	NULL
23	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
C-terminal	NULL
DBD	NULL
region	NULL
,	NULL
YA	NULL
(	NULL
DBDAC23	NULL
)	NULL
(	NULL
lane	NULL
14	NULL
)	NULL
,	NULL
but	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
YA	NULL
(	NULL
ADBD	NULL
)	NULL
that	NULL
lacked	NULL
the	NULL
highly	NULL
conserved	NULL
DBD	NULL
region	NULL
(	NULL
Zane	NULL
13	NULL
)	NULL
.	NULL

GST-YA	NULL
(	NULL
DBDAC23	NULL
)	NULL
fails	NULL
to	NULL
support	NULL
CCAAT-box	NULL
DNA	NULL
binding	NULL
activity	NULL
when	NULL
recombined	NULL
with	NULL
full-length	NULL
NF-YB	NULL
:	NULL
C.	NULL
``	NULL
These	NULL
results	NULL
suggest	NULL
that	NULL
internally	NULL
and	NULL
externally	NULL
phosphorylated	NULL
forms	NULL
of	NULL
PC4	NULL
,	NULL
as	NULL
modified	NULL
by	NULL
CKII	NULL
and	NULL
HMK	NULL
respectively	NULL
,	NULL
do	NULL
not	NULL
impair	NULL
or	NULL
block	NULL
interaction	NULL
with	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
that	NULL
the	NULL
PC4	NULL
interac-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
18226	NULL
NF-Y	NULL
-associated	NULL
Cofactors	NULL
in	NULL
Stage-specific	NULL
B-cells	NULL
A	NULL
'	NULL
C	NULL
0.3	NULL
M	NULL
0.6	NULL
M	NULL
1.0	NULL
M	NULL
0.3	NULL
M	NULL
__	NULL
0.6	NULL
M__	NULL
1.0	NULL
M	NULL
|	NULL
|	NULL
|	NULL
NF-Y	NULL
-	NULL
v	NULL
bolus	NULL
~	NULL
B	NULL
D	NULL
NF-Y	NULL
-	NULL
U	NULL
it	NULL
bs	NULL
NF-Y	NULL
-	NULL
W	NULL
bs	NULL
but	NULL
|	NULL
|	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
T	NULL
P	NULL
OL	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Ll	NULL
M	NULL
2	NULL
13	NULL
14	NULL
1S	NULL
16	NULL
17	NULL
1	NULL
8	NULL
9	NULL
10	NULL
1	NULL
POL	NULL
b	NULL
2	NULL
3	NULL
4	NULL
|	NULL
)	NULL
I	NULL
|	NULL
0	NULL
1	NULL
1	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Recombination	NULL
of	NULL
the	NULL
A20	NULL
YAF	NULL
fraction	NULL
with	NULL
depleted	NULL
A20	NULL
and	NULL
MPC	NULL
11	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
nuclear	NULL
extract	NULL
fractions	NULL
reconstitutes	NULL
high	NULL
affinity	NULL
NF-Y	NULL
complex	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
.	NULL

A20	NULL
nuclear	NULL
extracts	NULL
were	NULL
depleted	NULL
of	NULL
YAF	NULL
proteins	NULL
and	NULL
tested	NULL
for	NULL
Q*	NULL
Sepharose	NULL
binding	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
A20	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
fraction	NULL
,	NULL
and	NULL
MPC11	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
fraction	NULL
derived	NULL
from	NULL
depleted	NULL
nuclear	NULL
extracts	NULL
were	NULL
recombined	NULL
with	NULL
A20	NULL
YAFs	NULL
,	NULL
then	NULL
tested	NULL
for	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
(	NULL
B	NULL
and	NULL
D	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

An	NULL
A20	NULL
YAF	NULL
fraction	NULL
was	NULL
depleted	NULL
of	NULL
protein	NULL
using	NULL
StrataClean	NULL
resin	NULL
,	NULL
recombined	NULL
with	NULL
the	NULL
A20	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
fraction	NULL
,	NULL
and	NULL
the	NULL
complex	NULL
tested	NULL
for	NULL
Q*	NULL
Sepharose	NULL
binding	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
KCl	NULL
step	NULL
gradient	NULL
are	NULL
shown	NULL
above	NULL
A	NULL
and	NULL
C.	NULL
Lane	NULL
P	NULL
,	NULL
free	NULL
``	NULL
Â°P-Ea	NULL
DNA	NULL
probe	NULL
;	NULL
lane	NULL
L	NULL
,	NULL
column	NULL
load	NULL
material	NULL
.	NULL

Column	NULL
elution	NULL
and	NULL
EMSA	NULL
assay	NULL
conditions	NULL
were	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

A	NULL
0.3M	NULL
-	NULL
0.6M	NULL
_	NULL
1.0M	NULL
A	NULL
PCi	NULL
BSA	NULL
B	NULL
PCA	NULL
_	NULL
BSA	NULL
_	NULL
I	NULL
|	NULL
|	NULL
cs	NULL
NF-Y	NULL
-	NULL
u	NULL
it	NULL
ls	NULL
L	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
111213141516	NULL
1718	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Recombinant	NULL
PC4	NULL
restores	NULL
Q*	NULL
Sepharose	NULL
binding	NULL
properties	NULL
to	NULL
the	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
complex	NULL
.	NULL

Affinity-purified	NULL
NF-Y	NULL
derived	NULL
from	NULL
A20-depleted	NULL
nuclear	NULL
extracts	NULL
was	NULL
recombined	NULL
with	NULL
recombinant	NULL
PC4	NULL
(	NULL
A	NULL
)	NULL
or	NULL
BSA	NULL
(	NULL
B	NULL
)	NULL
and	NULL
assayed	NULL
for	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
KC	NULL
]	NULL
step	NULL
gradient	NULL
are	NULL
shown	NULL
above	NULL
A	NULL
.	NULL

Column	NULL
elution	NULL
and	NULL
EMSA	NULL
assay	NULL
conditions	NULL
were	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Lane	NULL
L	NULL
,	NULL
column	NULL
load	NULL
material	NULL
;	NULL
lanes	NULL
1-17	NULL
,	NULL
Q*	NULL
Sepharose	NULL
column	NULL
fractions	NULL
.	NULL

tion	NULL
site	NULL
maps	NULL
to	NULL
the	NULL
subunit	NULL
interaction	NULL
subdomain	NULL
in	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
,	NULL
which	NULL
is	NULL
responsible	NULL
for	NULL
interaction	NULL
with	NULL
the	NULL
YB	NULL
:	NULL
C	NULL
heterodimer	NULL
(	NULL
82	NULL
,	NULL
34	NULL
)	NULL
.	NULL

A	NULL
group	NULL
of	NULL
MHC	NULL
class	NULL
II~	NULL
cell	NULL
lines	NULL
have	NULL
been	NULL
established	NULL
from	NULL
several	NULL
human	NULL
BLS	NULL
patients	NULL
'	NULL
B-cells	NULL
,	NULL
and	NULL
from	NULL
several	NULL
class	NULL
II*	NULL
mature	NULL
human	NULL
Burkitt	NULL
's	NULL
B-cell	NULL
lymphoma	NULL
cell	NULL
lines	NULL
by	NULL
y-irradi-ation	NULL
or	NULL
chemical	NULL
mutagenesis	NULL
,	NULL
and	NULL
immunoselected	NULL
for	NULL
the	NULL
loss	NULL
wo	NULL
P	NULL
tth	NULL
<	NULL
Â»	NULL
=~	NULL
â	NULL
w	NULL
â	NULL
-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

NF-Y	NULL
binding	NULL
to	NULL
CCAAT-box	NULL
DNA	NULL
elements	NULL
is	NULL
stabilized	NULL
by	NULL
recombinant	NULL
PC4	NULL
in	NULL
vitro	NULL
.	NULL

EMSA	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
affinity-purified	NULL
native	NULL
A20	NULL
NF-Y	NULL
complex	NULL
,	NULL
recombinant	NULL
PC4	NULL
,	NULL
and	NULL
the	NULL
Ea	NULL
(	NULL
A	NULL
)	NULL
and	NULL
S-collagen	NULL
(	NULL
B	NULL
)	NULL
CCAAT-box	NULL
DNA	NULL
oligonucleotide	NULL
probes	NULL
.	NULL

In	NULL
A	NULL
and	NULL
B	NULL
,	NULL
all	NULL
lanes	NULL
,	NULL
except	NULL
lane	NULL
1	NULL
,	NULL
received	NULL
~5	NULL
pug	NULL
of	NULL
NF-Y	NULL
protein	NULL
fraction	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
Â°P-probe	NULL
alone	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
no	NULL
PCA4	NULL
or	NULL
BSA	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
~25	NULL
ng	NULL
of	NULL
PC4	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
~50	NULL
ng	NULL
of	NULL
PC4	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
~25	NULL
ng	NULL
of	NULL
BSA	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
~50	NULL
ng	NULL
of	NULL
BSA	NULL
.	NULL

of	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
(	NULL
6	NULL
)	NULL
.	NULL

These	NULL
BLS	NULL
class	NULL
II~	NULL
B-cell	NULL
lines	NULL
have	NULL
been	NULL
placed	NULL
into	NULL
four	NULL
genetic	NULL
complementation	NULL
groups	NULL
,	NULL
where	NULL
each	NULL
group	NULL
represents	NULL
a	NULL
unique	NULL
defect	NULL
in	NULL
a	NULL
gene	NULL
product	NULL
involved	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
genetic	NULL
defect	NULL
in	NULL
BLS	NULL
group	NULL
II	NULL
,	NULL
CIITA	NULL
,	NULL
is	NULL
thought	NULL
to	NULL
function	NULL
as	NULL
a	NULL
tissue-specific	NULL
class	NULL
II	NULL
gene	NULL
transcriptional	NULL
cofactor	NULL
(	NULL
40	NULL
)	NULL
,	NULL
and	NULL
the	NULL
genetic	NULL
defect	NULL
in	NULL
BLS	NULL
group	NULL
IV	NULL
,	NULL
RFX5	NULL
,	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
large	NULL
subunit	NULL
of	NULL
the	NULL
X-box	NULL
DNA-binding	NULL
factor	NULL
,	NULL
RFX	NULL
(	NULL
54	NULL
)	NULL
.	NULL

The	NULL
NF-Y	NULL
complex	NULL
derived	NULL
from	NULL
the	NULL
BLS	NULL
group	NULL
II	NULL
cell	NULL
lines	NULL
,	NULL
RJ2.2.5	NULL
and	NULL
RM3	NULL
,	NULL
were	NULL
compared	NULL
with	NULL
their	NULL
parental	NULL
B-cell	NULL
line	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
a	NULL
BLS	NULL
group	NULL
III	NULL
cell	NULL
line	NULL
,	NULL
6.1.6	NULL
,	NULL
for	NULL
high	NULL
affinity	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

The	NULL
NF-Y	NULL
complex	NULL
derived	NULL
from	NULL
both	NULL
BLS	NULL
Group	NULL
II	NULL
cell	NULL
lines	NULL
,	NULL
RJ2.2.5	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
and	NULL
RM3	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
,	NULL
dissociated	NULL
following	NULL
anion	NULL
exchange	NULL
chromatography	NULL
into	NULL
NF-Y	NULL
subunits	NULL
fractions	NULL
in	NULL
a	NULL
manner	NULL
identical	NULL
to	NULL
MPC11	NULL
NF-Y	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
and	NULL
as	NULL
shown	NULL
using	NULL
complementing	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
subunit	NULL
fractions	NULL
in	NULL
EMSA	NULL
.	NULL
``	NULL

In	NULL
contrast	NULL
,	NULL
NF-Y	NULL
derived	NULL
from	NULL
the	NULL
class	NULL
IIC	NULL
,	NULL
and	NULL
CIITA*Â®	NULL
BLS	NULL
group	NULL
III	NULL
cell	NULL
line	NULL
,	NULL
6.1.6	NULL
(	NULL
panel	NULL
D	NULL
)	NULL
,	NULL
and	NULL
the	NULL
class	NULL
II*	NULL
mature	NULL
B-cell	NULL
,	NULL
Raji	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
,	NULL
eluted	NULL
from	NULL
Q*	NULL
Sepharose	NULL
as	NULL
an	NULL
intact	NULL
mul-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
NF-Y	NULL
-associated	NULL
Cofactors	NULL
in	NULL
Stage-specific	NULL
B-cells	NULL
A	NULL
â¬	NULL
>	NULL
Â§	NULL
i	NULL
te	NULL
@	NULL
]	NULL
a	NULL
08	NULL
3	NULL
&	NULL
3	NULL
$	NULL
g	NULL
$	NULL
a	NULL
a	NULL
a	NULL
&	NULL
A	NULL
R	NULL
m	NULL
Â©	NULL
0	NULL
5	NULL
0	NULL
0	NULL
G	NULL
62-32-	NULL
Â«	NULL
ame	NULL
Â«	NULL
te	NULL
1	NULL
%	NULL
3	NULL
4	NULL
%	NULL
6	NULL
7	NULL
li	NULL
Â§	NULL
o	NULL
A	NULL
a	NULL
A	NULL
a	NULL
A	NULL
a	NULL
a	NULL
&	NULL
&	NULL
a	NULL
2	NULL
&	NULL
&	NULL
e	NULL
e	NULL
e	NULL
:	NULL
a	NULL
2	NULL
&	NULL
nfff	NULL
hot	NULL
Bo	NULL
Bo	NULL
&	NULL
Bo	NULL
&	NULL
a	NULL
b	NULL
k	NULL
b	NULL
B	NULL
5	NULL
k	NULL
bk	NULL
O	NULL
62-32-	NULL
cou	NULL
cme	NULL
..	NULL
comme	NULL
..	NULL
cfb	NULL
cam	NULL
<	NULL
a	NULL
Â»	NULL
..	NULL
agh	NULL
Io	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

NF-YA	NULL
(	NULL
DBD	NULL
)	NULL
interacts	NULL
with	NULL
PC4	NULL
in	NULL
solution	NULL
.	NULL

GST-NF-YA	NULL
(	NULL
DBD	NULL
)	NULL
was	NULL
expressed	NULL
from	NULL
pYA	NULL
2TK	NULL
(	NULL
DBD	NULL
)	NULL
,	NULL
purified	NULL
,	NULL
then	NULL
cleaved	NULL
from	NULL
GST	NULL
with	NULL
thrombin	NULL
.	NULL

Purified	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
was	NULL
*Â°P-labeled	NULL
in	NULL
vitro	NULL
with	NULL
HMK	NULL
,	NULL
incubated	NULL
with	NULL
GST	NULL
,	NULL
GST-PC4	NULL
,	NULL
a	NULL
series	NULL
of	NULL
GST-PC4	NULL
deletion	NULL
mutants	NULL
,	NULL
and	NULL
GST-Dr1	NULL
bound	NULL
to	NULL
glutathione-agarose	NULL
beads	NULL
in	NULL
A	NULL
.	NULL

Retained	NULL
*Â°P-YA	NULL
(	NULL
DBD	NULL
)	NULL
was	NULL
assayed	NULL
using	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
glutathione-agarose	NULL
beads	NULL
alone	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
GST	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
GST-PC4	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
GST-	NULL
PC4	NULL
(	NULL
AC37	NULL
)	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
GST-PC4	NULL
(	NULL
C37	NULL
)	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
GST-Dr1	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
GST-PC4	NULL
(	NULL
ANG64	NULL
)	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
denoted	NULL
at	NULL
the	NULL
left	NULL
in	NULL
kilodaltons	NULL
.	NULL

GST-PC4	NULL
was	NULL
expressed	NULL
from	NULL
pPC4	NULL
2TK	NULL
,	NULL
purified	NULL
,	NULL
cleaved	NULL
from	NULL
GST	NULL
with	NULL
thrombin	NULL
,	NULL
and	NULL
purified	NULL
.	NULL

PC4	NULL
was	NULL
*Â°P-labeled	NULL
in	NULL
vitro	NULL
using	NULL
CK	NULL
II	NULL
(	NULL
lanes	NULL
1-9	NULL
)	NULL
or	NULL
HMK	NULL
(	NULL
lanes	NULL
10-14	NULL
)	NULL
,	NULL
then	NULL
incubated	NULL
with	NULL
GST	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
GST	NULL
fusion	NULL
proteins	NULL
bound	NULL
to	NULL
glutathione-agarose	NULL
beads	NULL
in	NULL
B	NULL
.	NULL

Retained	NULL
*Â°P-PC4	NULL
was	NULL
assayed	NULL
using	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
10	NULL
,	NULL
glutathione-agarose	NULL
beads	NULL
alone	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
11	NULL
,	NULL
GST	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
GST-YA/His-YB/His-YC	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
GST-YA	NULL
;	NULL
lanes	NULL
5	NULL
and	NULL
13	NULL
,	NULL
GST-YA	NULL
(	NULL
ADBD	NULL
)	NULL
;	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
,	NULL
GST-YA	NULL
(	NULL
DBD	NULL
)	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
GST-Drl	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
GST-TFIIB	NULL
;	NULL
lane	NULL
9	NULL
,	NULL
GST-HAP2	NULL
(	NULL
DBD	NULL
)	NULL
;	NULL
lane	NULL
14	NULL
,	NULL
GST-YA	NULL
(	NULL
DBD	NULL
AC23	NULL
)	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
denoted	NULL
at	NULL
the	NULL
left	NULL
in	NULL
kilodaltons	NULL
.	NULL

timeric	NULL
complex	NULL
in	NULL
a	NULL
manner	NULL
identical	NULL
to	NULL
the	NULL
mature	NULL
B-cell	NULL
line	NULL
,	NULL
A20	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
inactivation	NULL
of	NULL
the	NULL
B-cell-specific	NULL
class	NULL
II	NULL
gene	NULL
factor	NULL
,	NULL
CIITA	NULL
,	NULL
in	NULL
BLS	NULL
group	NULL
II	NULL
cell	NULL
lines	NULL
is	NULL
associated	NULL
with	NULL
dissociation	NULL
of	NULL
the	NULL
NF-Y	NULL
subunit	NULL
structure	NULL
following	NULL
anion	NULL
exchange	NULL
analysis	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
functional	NULL
CIITA	NULL
in	NULL
both	NULL
``	NULL
normal	NULL
``	NULL
MHC	NULL
class	NULL
II*	NULL
mature	NULL
B-cell	NULL
lines	NULL
(	NULL
eg	NULL
.	NULL

A20	NULL
,	NULL
Raji	NULL
)	NULL
,	NULL
and	NULL
in	NULL
a	NULL
BLS	NULL
group	NULL
III	NULL
cell	NULL
line	NULL
,	NULL
6.1.6	NULL
,	NULL
results	NULL
in	NULL
an	NULL
NF-Y	NULL
subunit	NULL
structure	NULL
that	NULL
elutes	NULL
as	NULL
an	NULL
intact	NULL
multimeric	NULL
complex	NULL
from	NULL
anion	NULL
exchangers	NULL
.	NULL

These	NULL
results	NULL
further	NULL
suggest	NULL
that	NULL
CIITA	NULL
may	NULL
directly	NULL
or	NULL
indirectly	NULL
modulate	NULL
the	NULL
activity	NULL
of	NULL
PC4	NULL
,	NULL
in	NULL
effect	NULL
regulating	NULL
its	NULL
ability	NULL
to	NULL
stabilize	NULL
NF-Y	NULL
subunit	NULL
interactions	NULL
.	NULL

DISCUSSION	NULL
Differential	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
during	NULL
B	NULL
lymphocyte	NULL
development	NULL
represents	NULL
an	NULL
attractive	NULL
system	NULL
for	NULL
studying	NULL
the	NULL
transcriptional	NULL
mechanisms	NULL
underlying	NULL
tissue	NULL
18227	NULL
specific	NULL
gene	NULL
activation	NULL
and	NULL
repression	NULL
.	NULL

Human	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
are	NULL
activated	NULL
at	NULL
the	NULL
mature	NULL
B-cell	NULL
stage	NULL
;	NULL
however	NULL
,	NULL
progression	NULL
to	NULL
the	NULL
plasma	NULL
B-cell	NULL
stage	NULL
following	NULL
stimulation	NULL
with	NULL
foreign	NULL
antigens	NULL
,	NULL
various	NULL
mitogens	NULL
,	NULL
and	NULL
T-cell	NULL
factors	NULL
results	NULL
in	NULL
uniform	NULL
repression	NULL
of	NULL
all	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

A	NULL
number	NULL
of	NULL
ubiquitous	NULL
transcription	NULL
factors	NULL
,	NULL
together	NULL
with	NULL
the	NULL
B-cell-specific	NULL
cofactors	NULL
,	NULL
CIITA	NULL
(	NULL
6	NULL
)	NULL
and	NULL
the	NULL
Oct	NULL
coactivator	NULL
from	NULL
B-cells	NULL
(	NULL
56	NULL
)	NULL
,	NULL
are	NULL
believed	NULL
to	NULL
play	NULL
critical	NULL
regulatory	NULL
roles	NULL
in	NULL
stage-specific	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
;	NULL
however	NULL
,	NULL
the	NULL
mechanistic	NULL
steps	NULL
involved	NULL
in	NULL
creating	NULL
an	NULL
active	NULL
class	NULL
II	NULL
initiation	NULL
complex	NULL
and	NULL
possible	NULL
functional	NULL
interactions	NULL
between	NULL
these	NULL
general	NULL
activators	NULL
,	NULL
B-cell-specific	NULL
cofactors	NULL
,	NULL
and	NULL
basic	NULL
components	NULL
of	NULL
the	NULL
RNA	NULL
polymerase	NULL
II	NULL
machinery	NULL
remain	NULL
poorly	NULL
understood	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
biochemical	NULL
properties	NULL
of	NULL
the	NULL
multimeric	NULL
NF-Y	NULL
complex	NULL
have	NULL
been	NULL
investigated	NULL
and	NULL
compared	NULL
in	NULL
stage-specific	NULL
B-cells	NULL
in	NULL
an	NULL
effort	NULL
to	NULL
identify	NULL
structural	NULL
components	NULL
in	NULL
the	NULL
NF-Y	NULL
complex	NULL
that	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
regulating	NULL
NF-Y	NULL
function	NULL
during	NULL
states	NULL
of	NULL
active	NULL
and	NULL
repressed	NULL
class	NULL
II	NULL
tran-scription	NULL
,	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
functional	NULL
class	NULL
II	NULL
initiation	NULL
complex	NULL
.	NULL

The	NULL
main	NULL
observations	NULL
from	NULL
this	NULL
study	NULL
are	NULL
as	NULL
follows	NULL
.	NULL

1	NULL
)	NULL
The	NULL
NF-Y	NULL
complex	NULL
derived	NULL
from	NULL
MHC	NULL
class	NULL
II	NULL
*	NULL
B-cells	NULL
binds	NULL
to	NULL
anion	NULL
exchangers	NULL
with	NULL
high	NULL
affinity	NULL
as	NULL
an	NULL
intact	NULL
trimeric	NULL
species	NULL
,	NULL
whereas	NULL
NF-Y	NULL
derived	NULL
from	NULL
MHC	NULL
class	NULL
II~	NULL
plasma	NULL
B-cells	NULL
and	NULL
BLS	NULL
group	NULL
II	NULL
cells	NULL
dissociates	NULL
into	NULL
discrete	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
subunit	NULL
fractions	NULL
.	NULL

2	NULL
)	NULL
The	NULL
NF-Y	NULL
complex	NULL
in	NULL
mature	NULL
B-cells	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
low	NULL
molecular	NULL
mass	NULL
protein	NULL
fraction	NULL
(	NULL
YAFs	NULL
)	NULL
,	NULL
which	NULL
accounts	NULL
for	NULL
the	NULL
NF-Y	NULL
Q*	NULL
binding	NULL
phenotype	NULL
(	NULL
i.e	NULL
.	NULL

transfer	NULL
of	NULL
the	NULL
YAF	NULL
fraction	NULL
to	NULL
a	NULL
YAF-depleted	NULL
mature	NULL
B-cell	NULL
NF-Y	NULL
complex	NULL
,	NULL
or	NULL
a	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
complex	NULL
derived	NULL
from	NULL
class	NULL
II~	NULL
cells	NULL
fully	NULL
restores	NULL
NF-Y	NULL
Q*	NULL
binding	NULL
.	NULL

3	NULL
)	NULL
Recombinant	NULL
PC4	NULL
restores	NULL
high	NULL
affinity	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
binding	NULL
to	NULL
Q*	NULL
Sepharose	NULL
,	NULL
and	NULL
significantly	NULL
stabilizes	NULL
native	NULL
NF-Y	NULL
:	NULL
CCAAT-box	NULL
DNA	NULL
interactions	NULL
in	NULL
vitro	NULL
.	NULL

Anion	NULL
exchange	NULL
analysis	NULL
of	NULL
the	NULL
NF-Y	NULL
complex	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
MHC	NULL
class	NULL
II*	NULL
mature	NULL
B-cell	NULL
lines	NULL
have	NULL
shown	NULL
NF-Y	NULL
to	NULL
elute	NULL
as	NULL
an	NULL
intact	NULL
trimeric	NULL
complex	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analyses	NULL
of	NULL
the	NULL
A20	NULL
Q*	NULL
fractions	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
using	NULL
affinity-purified	NULL
a-YA	NULL
and	NULL
Â«	NULL
-YB	NULL
antibodies	NULL
,	NULL
also	NULL
confirmed	NULL
that	NULL
the	NULL
YA	NULL
and	NULL
YB	NULL
subunits	NULL
coelute	NULL
in	NULL
the	NULL
0.6	NULL
M	NULL
KCl	NULL
fraction	NULL
.	NULL
``	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
NF-Y	NULL
complex	NULL
derived	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
murine	NULL
class	NULL
II~	NULL
plasma	NULL
B-cell	NULL
lines	NULL
,	NULL
several	NULL
other	NULL
class	NULL
II~	NULL
cell	NULL
types	NULL
(	NULL
e.g	NULL
.	NULL

P388D1	NULL
,	NULL
3T3-L1	NULL
,	NULL
TA1	NULL
,	NULL
C3H10T1/2	NULL
)	NULL
,	NULL
and	NULL
shown	NULL
previously	NULL
in	NULL
Hela	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
NIH	NULL
3T3	NULL
(	NULL
27	NULL
)	NULL
cell	NULL
lines	NULL
,	NULL
dissociates	NULL
into	NULL
discrete	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
subunit	NULL
fractions	NULL
following	NULL
Q*	NULL
analysis	NULL
.	NULL

These	NULL
observations	NULL
together	NULL
with	NULL
NF-Y	NULL
subunit	NULL
recombination	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
suggest	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
subunit	NULL
interactions	NULL
are	NULL
stabilized	NULL
in	NULL
class	NULL
II*	NULL
mature	NULL
B-cells	NULL
,	NULL
in	NULL
comparison	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
class	NULL
II~	NULL
cell	NULL
types	NULL
.	NULL

To	NULL
test	NULL
these	NULL
conclusions	NULL
further	NULL
,	NULL
the	NULL
anion	NULL
exchange	NULL
properties	NULL
of	NULL
NF-Y	NULL
were	NULL
examined	NULL
in	NULL
the	NULL
murine	NULL
monocyte/macrophage	NULL
cell	NULL
line	NULL
,	NULL
P388D1	NULL
,	NULL
during	NULL
IFN-y-mediated	NULL
dif-ferentiation	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
IFN-y	NULL
,	NULL
NF-Y	NULL
dissociated	NULL
into	NULL
YA	NULL
and	NULL
YB	NULL
:	NULL
C	NULL
fractions	NULL
,	NULL
whereas	NULL
NF-Y	NULL
eluted	NULL
as	NULL
the	NULL
trimeric	NULL
complex	NULL
following	NULL
IFN-y-mediated	NULL
induction	NULL
of	NULL
class	NULL
II	NULL
transcription	NULL
.	NULL
``	NULL

These	NULL
comparisons	NULL
suggest	NULL
that	NULL
the	NULL
anion	NULL
exchange	NULL
properties	NULL
of	NULL
NF-Y	NULL
are	NULL
significantly	NULL
altered	NULL
during	NULL
periods	NULL
of	NULL
active	NULL
,	NULL
inactive	NULL
,	NULL
or	NULL
repressed	NULL
MHC	NULL
class	NULL
II	NULL
transcription	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
report	NULL
,	NULL
physical	NULL
interaction	NULL
between	NULL
NF-Y	NULL
and	NULL
the	NULL
transcriptional	NULL
coactivator	NULL
,	NULL
PC4	NULL
,	NULL
was	NULL
demonstrated	NULL
in	NULL
vitro	NULL
using	NULL
far	NULL
Western	NULL
assays	NULL
,	NULL
and	NULL
mapped	NULL
to	NULL
the	NULL
highly	NULL
conserved	NULL
DBD	NULL
element	NULL
in	NULL
the	NULL
NF-YA	NULL
subunit	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Biochemical	NULL
characterization	NULL
of	NULL
the	NULL
YAF	NULL
fraction	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
and	NULL
these	NULL
initial	NULL
studies	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
PC4	NULL
was	NULL
associated	NULL
with	NULL
NF-Y	NULL
in	NULL
stage-specific	NULL
B-cells	NULL
,	NULL
and	NULL
responsible	NULL
for	NULL
the	NULL
NF-Y	NULL
Q*	NULL
binding	NULL
properties	NULL
.	NULL

Recombination	NULL
of	NULL
affinity-purified	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
with	NULL
recombinant	NULL
PC4	NULL
resulted	NULL
in	NULL
conver-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
18228	NULL
A	NULL
0.3	NULL
M	NULL
0.6	NULL
M	NULL
1.0	NULL
M	NULL
|	NULL
|	NULL
|	NULL
NBy	NULL
-	NULL
u	NULL
U	NULL
B	NULL
RJ2.2.5	NULL
_	NULL
u	NULL
NF-Y	NULL
PLL	NULL
23	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
111213	NULL
14	NULL
15	NULL
16	NULL
17	NULL
NF-Y	NULL
-associated	NULL
Cofactors	NULL
in	NULL
Stage-specific	NULL
B-cells	NULL
C	NULL
0.3	NULL
M	NULL
0.6	NULL
M	NULL
__	NULL
1.0	NULL
M	NULL
|	NULL
|	NULL
I	NULL
D	NULL
6.1	NULL
.	NULL

N	NULL
LOP	NULL
LD	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
#	NULL
9	NULL
10	NULL
I1	NULL
12	NULL
13	NULL
14	NULL
15	NULL
1617	NULL
Fic	NULL
.	NULL

10	NULL
.	NULL

Comparison	NULL
of	NULL
NF-Y	NULL
Q*	NULL
Sepharose	NULL
binding	NULL
properties	NULL
in	NULL
MHC	NULL
class	NULL
II~	NULL
human	NULL
mutant	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
B-cell	NULL
lines	NULL
.	NULL

NF-Y	NULL
derived	NULL
from	NULL
B-cell	NULL
lines	NULL
representing	NULL
the	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
complementation	NULL
group	NULL
II	NULL
:	NULL
RJ2.2.5	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
RMS	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
complementation	NULL
group	NULL
III	NULL
:	NULL
6.1.6	NULL
(	NULL
D	NULL
)	NULL
,	NULL
were	NULL
compared	NULL
with	NULL
the	NULL
RJ2.2.5	NULL
and	NULL
RM3	NULL
parental	NULL
class	NULL
II*	NULL
B-cell	NULL
line	NULL
,	NULL
Raji	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Column	NULL
elution	NULL
and	NULL
EMSA	NULL
assay	NULL
conditions	NULL
were	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
KCl	NULL
step	NULL
gradient	NULL
are	NULL
shown	NULL
above	NULL
A	NULL
and	NULL
C.	NULL
Lane	NULL
P	NULL
,	NULL
free	NULL
*Â°P-Ea	NULL
DNA	NULL
probe	NULL
;	NULL
lane	NULL
L	NULL
,	NULL
column	NULL
load	NULL
material	NULL
;	NULL
lanes	NULL
I-17	NULL
,	NULL
Q*	NULL
column	NULL
fractions	NULL
.	NULL

sion	NULL
of	NULL
NF-Y	NULL
into	NULL
a	NULL
complex	NULL
that	NULL
bound	NULL
Q*	NULL
Sepharose	NULL
in	NULL
a	NULL
manner	NULL
indistinguishable	NULL
from	NULL
mature	NULL
B-cell	NULL
NF-Y	NULL
,	NULL
and	NULL
NF-Y	NULL
reconstituted	NULL
with	NULL
the	NULL
mature	NULL
B-cell	NULL
YAF	NULL
fraction	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
PC4	NULL
is	NULL
the	NULL
YAF	NULL
component	NULL
,	NULL
which	NULL
itself	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
conferring	NULL
the	NULL
Q+	NULL
binding	NULL
phenotype	NULL
to	NULL
the	NULL
NF-YA	NULL
:	NULL
B	NULL
:	NULL
C	NULL
complex	NULL
.	NULL

PC4	NULL
is	NULL
known	NULL
to	NULL
be	NULL
phosphorylated	NULL
in	NULL
a	NULL
group	NULL
of	NULL
N-terminal	NULL
serine	NULL
residues	NULL
,	NULL
primarily	NULL
by	NULL
CKII	NULL
in	NULL
vivo	NULL
,	NULL
and	NULL
this	NULL
modification	NULL
of	NULL
has	NULL
been	NULL
shown	NULL
.	NULL

to	NULL
prevent	NULL
its	NULL
interaction	NULL
with	NULL
the	NULL
viral	NULL
activator	NULL
,	NULL
VP16	NULL
,	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
function	NULL
as	NULL
a	NULL
coactivator	NULL
in	NULL
vitro	NULL
(	NULL
48	NULL
)	NULL
.	NULL

The	NULL
PC4	NULL
recombination	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
non-phosphorylated	NULL
form	NULL
of	NULL
PC4	NULL
is	NULL
capable	NULL
of	NULL
conferring	NULL
the	NULL
high	NULL
affinity	NULL
Q*	NULL
binding	NULL
phenotype	NULL
to	NULL
NF-Y	NULL
,	NULL
and	NULL
further	NULL
suggest	NULL
that	NULL
PC4	NULL
may	NULL
be	NULL
differentially	NULL
regulated	NULL
by	NULL
phosphorylation/dephosphorylation	NULL
in	NULL
association	NULL
with	NULL
NF-Y	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
phosphorylated	NULL
forms	NULL
of	NULL
PC4	NULL
interact	NULL
with	NULL
NF-Y	NULL
,	NULL
PC4	NULL
was	NULL
phosphorylated	NULL
both	NULL
with	NULL
CKII	NULL
and	NULL
HMK	NULL
and	NULL
used	NULL
to	NULL
probe	NULL
a	NULL
series	NULL
of	NULL
GST	NULL
fusion	NULL
proteins	NULL
in	NULL
a	NULL
solution	NULL
pull-down	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Both	NULL
Â°Â°P-PC4	NULL
modified	NULL
forms	NULL
bound	NULL
to	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
,	NULL
and	NULL
not	NULL
to	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
of	NULL
YA	NULL
,	NULL
suggesting	NULL
that	NULL
phosphorylation	NULL
did	NULL
not	NULL
impair	NULL
this	NULL
interaction	NULL
,	NULL
and	NULL
that	NULL
the	NULL
general	NULL
nature	NULL
of	NULL
this	NULL
association	NULL
was	NULL
different	NULL
from	NULL
previous	NULL
studies	NULL
suggesting	NULL
an	NULL
interaction	NULL
between	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
PC4	NULL
and	NULL
the	NULL
activation	NULL
domains	NULL
of	NULL
VP16	NULL
(	NULL
48	NULL
)	NULL
,	NULL
and	NULL
GAL4-AH	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Of	NULL
particular	NULL
note	NULL
was	NULL
the	NULL
observation	NULL
that	NULL
Â°Â°P-PC4	NULL
interacted	NULL
with	NULL
the	NULL
subunit	NULL
interaction	NULL
subdomain	NULL
of	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
.	NULL

This	NULL
region	NULL
in	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
is	NULL
known	NULL
to	NULL
be	NULL
important	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
YA	NULL
with	NULL
the	NULL
YB	NULL
:	NULL
C	NULL
heterodimer	NULL
in	NULL
creation	NULL
of	NULL
a	NULL
unique	NULL
structure	NULL
,	NULL
which	NULL
then	NULL
recognizes	NULL
the	NULL
CCAAT-box	NULL
motif	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
DNA-binding	NULL
subdomain	NULL
of	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
,	NULL
which	NULL
prevent	NULL
interaction	NULL
with	NULL
CCAAT-box	NULL
motifs	NULL
,	NULL
did	NULL
not	NULL
impair	NULL
interaction	NULL
with	NULL
PC4	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
recombinant	NULL
PC4	NULL
was	NULL
observed	NULL
to	NULL
specifically	NULL
stabilize	NULL
NF-Y	NULL
:	NULL
CCAAT-	NULL
box	NULL
DNA	NULL
interactions	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
further	NULL
suggest	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
PC4	NULL
with	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
may	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
stabilizing	NULL
YA	NULL
interaction	NULL
with	NULL
YB	NULL
:	NULL
C	NULL
,	NULL
and	NULL
the	NULL
interaction	NULL
with	NULL
CCAAT-box	NULL
binding	NULL
sites	NULL
following	NULL
subunit	NULL
trimerization	NULL
.	NULL

Further	NULL
studies	NULL
will	NULL
be	NULL
aimed	NULL
at	NULL
determining	NULL
the	NULL
step	NULL
(	NULL
s	NULL
)	NULL
at	NULL
which	NULL
PC4	NULL
functions	NULL
in	NULL
these	NULL
processes	NULL
,	NULL
and	NULL
in	NULL
more	NULL
precisely	NULL
defining	NULL
the	NULL
region	NULL
and	NULL
amino	NULL
acids	NULL
in	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
that	NULL
support	NULL
this	NULL
interaction	NULL
.	NULL

To	NULL
more	NULL
accurately	NULL
define	NULL
the	NULL
region	NULL
in	NULL
PC4	NULL
that	NULL
interacts	NULL
with	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
,	NULL
a	NULL
series	NULL
of	NULL
GST-PC4	NULL
mutants	NULL
were	NULL
tested	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

The	NULL
N-terminal	NULL
CKII	NULL
phosphorylation	NULL
region	NULL
in	NULL
PC4	NULL
was	NULL
clearly	NULL
dispensable	NULL
for	NULL
this	NULL
interaction	NULL
,	NULL
while	NULL
the	NULL
C	NULL
terminus	NULL
near	NULL
amino	NULL
acid	NULL
90	NULL
appeared	NULL
to	NULL
be	NULL
an	NULL
important	NULL
interaction	NULL
site	NULL
.	NULL

Phosphorylation	NULL
of	NULL
PC4	NULL
by	NULL
CKII	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
induce	NULL
a	NULL
conformational	NULL
change	NULL
that	NULL
prevents	NULL
its	NULL
interaction	NULL
with	NULL
activation	NULL
regions	NULL
and	NULL
nullifies	NULL
its	NULL
positive	NULL
coactivator	NULL
functions	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Interaction	NULL
of	NULL
PC4	NULL
through	NULL
its	NULL
C-terminal	NULL
region	NULL
with	NULL
the	NULL
highly	NULL
conserved	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
region	NULL
suggests	NULL
PC4	NULL
may	NULL
function	NULL
in	NULL
a	NULL
unique	NULL
manner	NULL
when	NULL
bound	NULL
to	NULL
NF-Y	NULL
,	NULL
since	NULL
this	NULL
interaction	NULL
was	NULL
mapped	NULL
to	NULL
the	NULL
region	NULL
known	NULL
at	NULL
present	NULL
only	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
nonspecific	NULL
binding	NULL
to	NULL
single-strand	NULL
DNA	NULL
(	NULL
57	NULL
,	NULL
58	NULL
)	NULL
.	NULL

In	NULL
association	NULL
with	NULL
NF-Y	NULL
,	NULL
PC4	NULL
may	NULL
act	NULL
both	NULL
as	NULL
a	NULL
potent	NULL
activator	NULL
through	NULL
its	NULL
N-terminal	NULL
region	NULL
,	NULL
and	NULL
as	NULL
a	NULL
repressor	NULL
when	NULL
phosphorylated	NULL
by	NULL
CKII	NULL
since	NULL
both	NULL
forms	NULL
interact	NULL
with	NULL
YA	NULL
(	NULL
DBD	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PC4	NULL
may	NULL
regulate	NULL
NF-Y	NULL
CCAAT-box	NULL
DNA	NULL
binding	NULL
by	NULL
stabilizing	NULL
overall	NULL
subunit	NULL
interactions	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
increase	NULL
the	NULL
rate	NULL
of	NULL
NF-Y	NULL
association	NULL
with	NULL
its	NULL
DNA-binding	NULL
site	NULL
.	NULL

An	NULL
interaction	NULL
between	NULL
Â°Â°P-PCA4	NULL
(	NULL
CKIIT	NULL
)	NULL
and	NULL
TFIIB	NULL
was	NULL
also	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
this	NULL
observation	NULL
is	NULL
not	NULL
known	NULL
at	NULL
present	NULL
.	NULL

These	NULL
results	NULL
contrast	NULL
with	NULL
previous	NULL
studies	NULL
which	NULL
suggest	NULL
non-phosphorylated	NULL
human	NULL
PC4	NULL
interacts	NULL
with	NULL
TFIIA	NULL
,	NULL
and	NULL
not	NULL
TFIIB	NULL
,	NULL
in	NULL
vitro	NULL
(	NULL
59	NULL
)	NULL
,	NULL
and	NULL
with	NULL
Far	NULL
Western	NULL
assays	NULL
,	NULL
which	NULL
suggest	NULL
non-phosphorylated	NULL
SUB1	NULL
,	NULL
the	NULL
yeast	NULL
homolog	NULL
of	NULL
PC4	NULL
,	NULL
interacts	NULL
with	NULL
TFIIB	NULL
,	NULL
and	NULL
acts	NULL
as	NULL
a	NULL
clearance	NULL
factor	NULL
in	NULL
vivo	NULL
by	NULL
promoting	NULL
the	NULL
release	NULL
of	NULL
TFIIB	NULL
from	NULL
TBP	NULL
(	NULL
60	NULL
)	NULL
.	NULL

SUB1L	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
a	NULL
upstream	NULL
activating	NULL
sequence	NULL
reporter	NULL
~4-fold	NULL
in	NULL
yeast	NULL
which	NULL
contains	NULL
a	NULL
CCAAT-box	NULL
DNA-binding	NULL
site	NULL
for	NULL
HAP2/3/4/5	NULL
,	NULL
the	NULL
yeast	NULL
homolog	NULL
of	NULL
NF-Y	NULL
(	NULL
60	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
PC4	NULL
may	NULL
also	NULL
play	NULL
a	NULL
functional	NULL
role	NULL
in	NULL
mediating	NULL
NF-Y	NULL
transactivation	NULL
potential	NULL
in	NULL
vivo	NULL
,	NULL
and	NULL
warrant	NULL
further	NULL
investigation	NULL
into	NULL
the	NULL
functional	NULL
relationships	NULL
between	NULL
NF-Y	NULL
,	NULL
PC4	NULL
,	NULL
TFIIA	NULL
,	NULL
TFIIB	NULL
,	NULL
TBP	NULL
,	NULL
and	NULL
their	NULL
concerted	NULL
mecha-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
NF-Y	NULL
-associated	NULL
Cofactors	NULL
in	NULL
Stage-specific	NULL
B-cells	NULL
nism	NULL
of	NULL
action	NULL
within	NULL
NF-Y	NULL
CCAAT-box	NULL
containing	NULL
promoters	NULL
.	NULL

Characterization	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
during	NULL
the	NULL
mature	NULL
to	NULL
plasma	NULL
B-cell	NULL
transition	NULL
,	NULL
and	NULL
in	NULL
somatic	NULL
plasma	NULL
:	NULL
mature	NULL
B-cell	NULL
hybrids	NULL
,	NULL
has	NULL
suggested	NULL
that	NULL
the	NULL
shift	NULL
from	NULL
active	NULL
to	NULL
inactive	NULL
class	NULL
II	NULL
transcription	NULL
involves	NULL
expression	NULL
of	NULL
a	NULL
dominant	NULL
plasma	NULL
B-cell	NULL
repressor	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
CIITA	NULL
in	NULL
plasma	NULL
cells	NULL
overrides	NULL
this	NULL
repression	NULL
and	NULL
restores	NULL
class	NULL
II	NULL
transcription	NULL
(	NULL
43	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
hypothesized	NULL
plasma	NULL
B-cell	NULL
repressor	NULL
may	NULL
act	NULL
not	NULL
on	NULL
class	NULL
II	NULL
promoters	NULL
directly	NULL
,	NULL
but	NULL
possibly	NULL
on	NULL
the	NULL
CIITA	NULL
promoter	NULL
itself	NULL
to	NULL
extinguish	NULL
CIITA	NULL
expression	NULL
.	NULL

These	NULL
comparative	NULL
analyses	NULL
between	NULL
stage-specific	NULL
B-cells	NULL
demonstrate	NULL
that	NULL
CIITA	NULL
plays	NULL
a	NULL
dominant	NULL
role	NULL
in	NULL
class	NULL
II	NULL
transcription	NULL
;	NULL
however	NULL
,	NULL
the	NULL
relationships	NULL
between	NULL
CIITA	NULL
expression	NULL
,	NULL
class	NULL
II	NULL
promoter	NULL
structure	NULL
,	NULL
and	NULL
additional	NULL
coactivator	NULL
proteins	NULL
in	NULL
relation	NULL
to	NULL
tissue-specific	NULL
transcriptional	NULL
initiation	NULL
remain	NULL
unclear	NULL
.	NULL

CIITA	NULL
functions	NULL
as	NULL
a	NULL
critical	NULL
nodal	NULL
point	NULL
in	NULL
class	NULL
II	NULL
gene	NULL
activation	NULL
,	NULL
and	NULL
transmission	NULL
of	NULL
its	NULL
signal	NULL
either	NULL
directly	NULL
,	NULL
or	NULL
through	NULL
downstream	NULL
effector	NULL
proteins	NULL
,	NULL
could	NULL
result	NULL
in	NULL
specific	NULL
alterations	NULL
in	NULL
the	NULL
structure	NULL
and	NULL
activity	NULL
of	NULL
the	NULL
known	NULL
class	NULL
II	NULL
transcription	NULL
factors	NULL
during	NULL
B-cell	NULL
development	NULL
.	NULL

Several	NULL
BLS	NULL
group	NULL
II	NULL
cell	NULL
lines	NULL
which	NULL
possess	NULL
defective	NULL
CIITA	NULL
genes	NULL
,	NULL
RJ2.2.5	NULL
and	NULL
RM3	NULL
,	NULL
and	NULL
are	NULL
class	NULL
II_	NULL
,	NULL
as	NULL
well	NULL
all	NULL
other	NULL
class	NULL
II~	NULL
non-B-cell	NULL
tested	NULL
here	NULL
,	NULL
exhibit	NULL
the	NULL
class	NULL
II~	NULL
NF-Y	NULL
Q*	NULL
phenotype	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
all	NULL
other	NULL
mature	NULL
B-cell	NULL
lines	NULL
that	NULL
express	NULL
CIITA	NULL
,	NULL
exhibit	NULL
the	NULL
class	NULL
II*	NULL
NF-Y	NULL
Q*	NULL
phenotype	NULL
.	NULL

The	NULL
CIITA*	NULL
BLS	NULL
group	NULL
III	NULL
cell	NULL
line	NULL
,	NULL
6.1.6	NULL
,	NULL
also	NULL
exhibits	NULL
the	NULL
mature	NULL
B-cell	NULL
NF-Y	NULL
Q*	NULL
phenotype	NULL
despite	NULL
absence	NULL
of	NULL
class	NULL
II	NULL
transcription	NULL
.	NULL

Collectively	NULL
these	NULL
comparative	NULL
analyses	NULL
from	NULL
a	NULL
diverse	NULL
set	NULL
of	NULL
cell	NULL
types	NULL
and	NULL
cellular	NULL
states	NULL
provide	NULL
support	NULL
for	NULL
the	NULL
suggestion	NULL
that	NULL
PC4	NULL
activation	NULL
is	NULL
linked	NULL
to	NULL
CIITA	NULL
expression	NULL
.	NULL

Transmission	NULL
of	NULL
the	NULL
biochemical	NULL
signal	NULL
initiated	NULL
by	NULL
CIITA	NULL
may	NULL
lead	NULL
to	NULL
conversion	NULL
of	NULL
PC4	NULL
from	NULL
the	NULL
phosphorylated	NULL
to	NULL
non-phosphorylated	NULL
form	NULL
,	NULL
and	NULL
stabilization	NULL
of	NULL
NF-Y	NULL
subunit	NULL
interactions	NULL
.	NULL

The	NULL
accumulated	NULL
evidence	NULL
presented	NULL
in	NULL
this	NULL
study	NULL
supports	NULL
a	NULL
model	NULL
of	NULL
NF-Y	NULL
structure	NULL
based	NULL
on	NULL
a	NULL
unique	NULL
association	NULL
with	NULL
the	NULL
abundant	NULL
,	NULL
ubiquitously	NULL
expressed	NULL
cofactor	NULL
,	NULL
PC4	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
PC4	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
mediating	NULL
general	NULL
NF-Y	NULL
transcription	NULL
factor	NULL
functions	NULL
in	NULL
class	NULL
II~	NULL
cells	NULL
,	NULL
and	NULL
undergo	NULL
post-translational	NULL
modification	NULL
both	NULL
during	NULL
B-cell	NULL
development	NULL
and	NULL
during	NULL
IFN-y-induced	NULL
class	NULL
II	NULL
gene	NULL
activation	NULL
,	NULL
which	NULL
are	NULL
critical	NULL
to	NULL
NF-Y	NULL
function	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
.	NULL

Terminal	NULL
differentiation	NULL
into	NULL
the	NULL
plasma	NULL
B-cell	NULL
stage	NULL
may	NULL
signal	NULL
specific	NULL
PC4	NULL
phosphorylation	NULL
events	NULL
,	NULL
and	NULL
be	NULL
coupled	NULL
to	NULL
the	NULL
overall	NULL
process	NULL
of	NULL
extinguishing	NULL
class	NULL
II	NULL
transcription	NULL
.	NULL

Further	NULL
in	NULL
vitro	NULL
analyses	NULL
of	NULL
the	NULL
biochemical	NULL
nature	NULL
of	NULL
the	NULL
NF-Y	NULL
complex	NULL
in	NULL
stage-specific	NULL
B	NULL
lymphocytes	NULL
and	NULL
its	NULL
in	NULL
vivo	NULL
function	NULL
will	NULL
aid	NULL
elucidation	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
linking	NULL
NF-Y	NULL
function	NULL
with	NULL
PC4	NULL
activity	NULL
,	NULL
and	NULL
may	NULL
provide	NULL
insight	NULL
into	NULL
the	NULL
signals	NULL
initiated	NULL
by	NULL
CIITA	NULL
which	NULL
regulate	NULL
tissue-specific	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
.	NULL

Acknowledgments-I	NULL
thank	NULL
Drs	NULL
.	NULL

J.	NULL
Durkik	NULL
,	NULL
J.	NULL
Jones	NULL
,	NULL
B.	NULL
Mach	NULL
,	NULL
M.	NULL
Peterlin	NULL
,	NULL
and	NULL
D.	NULL
Pious	NULL
for	NULL
providing	NULL
cell	NULL
lines	NULL
;	NULL
H.	NULL
Ge	NULL
and	NULL
R.	NULL
Roeder	NULL
,	NULL
D.	NULL
McNabb	NULL
and	NULL
L.	NULL
Guarente	NULL
,	NULL
I.	NULL
Verma	NULL
,	NULL
D.	NULL
Reinberg	NULL
,	NULL
and	NULL
their	NULL
colleagues	NULL
for	NULL
providing	NULL
various	NULL
plasmids	NULL
;	NULL
and	NULL
Poornima	NULL
Bhat-Nakshatri	NULL
and	NULL
Raichal	NULL
Melathe	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Germain	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Margulies	NULL
,	NULL
D.	NULL
H.	NULL
(	NULL
1998	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11	NULL
,	NULL
403-450	NULL
2	NULL
.	NULL

Cresswell	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

4	NULL
,	NULL
541-548	NULL
3	NULL
.	NULL

Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
681-715	NULL
4	NULL
.	NULL

Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
Kara	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
13-49	NULL
5	NULL
.	NULL

Boss	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9	NULL
,	NULL
107-118	NULL
6	NULL
.	NULL

Mach	NULL
,	NULL
B.	NULL
,	NULL
Steimle	NULL
,	NULL
V.	NULL
,	NULL
Martinez-Soria	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Reith	NULL
,	NULL
W.	NULL
(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14	NULL
,	NULL
301-331	NULL
7	NULL
.	NULL

Dellabona	NULL
,	NULL
P.	NULL
,	NULL
Latron	NULL
,	NULL
F.	NULL
,	NULL
Maffei	NULL
,	NULL
A.	NULL
,	NULL
Scarpellino	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Accolla	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
2902-2910	NULL
8	NULL
.	NULL

Latron	NULL
,	NULL
F.	NULL
,	NULL
Jotterand-Bellomo	NULL
,	NULL
M.	NULL
,	NULL
Maffei	NULL
,	NULL
A.	NULL
,	NULL
Scarpellino	NULL
,	NULL
L.	NULL
,	NULL
Bernard	NULL
,	NULL
M.	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Accolla	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
2229-2233	NULL
9	NULL
.	NULL

Dedrick	NULL
,	NULL
R.	NULL
O.	NULL
,	NULL
and	NULL
Jones	NULL
,	NULL
P.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
598-604	NULL
10	NULL
.	NULL

Dorn	NULL
,	NULL
A.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Marfing	NULL
,	NULL
C.	NULL
,	NULL
LeMeur	NULL
,	NULL
M.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
18229	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
6249-6253	NULL
11	NULL
.	NULL

Tsang	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Nakanishi	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Peterlin	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
711-719	NULL
12	NULL
.	NULL

Vivile	NULL
,	NULL
S.	NULL
,	NULL
Jongeneel	NULL
,	NULL
V.	NULL
,	NULL
Koch	NULL
,	NULL
W.	NULL
,	NULL
Mantovani	NULL
,	NULL
R.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
8211-8217	NULL
13	NULL
.	NULL

Miwa	NULL
,	NULL
K.	NULL
,	NULL
Doyle	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
4939-4943	NULL
14	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
Barras	NULL
,	NULL
E.	NULL
,	NULL
Gaud	NULL
,	NULL
A.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Herrero-Sanchez	NULL
,	NULL
C.	NULL
,	NULL
Kobr	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1230-1244	NULL
15	NULL
.	NULL

Kara	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Ivashkiv	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1347-1357	NULL
16	NULL
.	NULL

Liou	NULL
,	NULL
H-C.	NULL
,	NULL
Boothby	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Finn	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Davidon	NULL
,	NULL
R.	NULL
,	NULL
Nabavi	NULL
,	NULL
N.	NULL
,	NULL
Zeleznik-Le	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Ting	NULL
,	NULL
J	NULL
.	NULL

P.-Y	NULL
.	NULL

,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
24	NULL
,	NULL
1581-1584	NULL
17	NULL
.	NULL

Dorn	NULL
,	NULL
A.	NULL
,	NULL
Bollekens	NULL
,	NULL
J.	NULL
,	NULL
Staub	NULL
,	NULL
A.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
50	NULL
,	NULL
863-872	NULL
18.	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Li	NULL
,	NULL
X.	NULL
Y.	NULL
,	NULL
Black	NULL
,	NULL
D.	NULL
,	NULL
Matthes	NULL
,	NULL
H.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
3119-3127	NULL
19	NULL
.	NULL

Vilen	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Cogswell	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
Ting	NULL
,	NULL
J.	NULL
P.-Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2406-2415	NULL
20	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
Siegrist	NULL
,	NULL
C.-A	NULL
.	NULL

,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Barras	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
554-558	NULL
21	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
Kobr	NULL
,	NULL
M.	NULL
,	NULL
Emery	NULL
,	NULL
P.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Siegrist	NULL
,	NULL
C.-A	NULL
.	NULL

,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
20020-20025	NULL
22	NULL
.	NULL

Wright	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Moore	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Vilen	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Brown	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
Ting	NULL
,	NULL
J.	NULL
P.-Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
20978-20986	NULL
28	NULL
.	NULL

Milos	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
Zaret	NULL
,	NULL
K.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
991-1004	NULL
24	NULL
.	NULL

Danilition	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Frederickson	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Taylor	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
and	NULL
Miyamoto	NULL
,	NULL
N.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
6913-6922	NULL
25	NULL
.	NULL

Dooley	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Millinder	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Osborne	NULL
,	NULL
T.	NULL
F.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
1349-1356	NULL
26	NULL
.	NULL

Chodosh	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Carthew	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
11-24	NULL
27	NULL
.	NULL

Hatamochi	NULL
,	NULL
A.	NULL
,	NULL
Golumbek	NULL
,	NULL
P.	NULL
T.	NULL
,	NULL
Van	NULL
Schaftingen	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
de	NULL
Crombrugghe	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2638	NULL
,	NULL
5940-5947	NULL
28	NULL
.	NULL

Chodosh	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Olesen	NULL
,	NULL
J.	NULL
,	NULL
Hahn	NULL
,	NULL
S.	NULL
,	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Guarente	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
25-35	NULL
29	NULL
.	NULL

Li	NULL
,	NULL
X-Y	NULL
.	NULL

,	NULL
Mantovani	NULL
,	NULL
R.	NULL
,	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Andre	NULL
,	NULL
I.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
1087-1091	NULL
30	NULL
.	NULL

Maity	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Vuorio	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
de	NULL
Crombrugghe	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
5878-	NULL
5882	NULL
31	NULL
.	NULL

Vuorio	NULL
,	NULL
T.	NULL
,	NULL
Maity	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
and	NULL
de	NULL
Crombrugghe	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
22480-22486	NULL
32	NULL
.	NULL

Maity	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
and	NULL
de	NULL
Crombrugghe	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
8286-8292	NULL
33	NULL
.	NULL

Becker	NULL
,	NULL
D.	NULL
M.	NULL
Fikes	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Guarente	NULL
,	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
1968-1972	NULL
34	NULL
.	NULL

Guarente	NULL
,	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
in	NULL
Transcriptional	NULL
Regulation	NULL
(	NULL
McKnight	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
K.	NULL
,	NULL
eds	NULL
)	NULL
Vol	NULL
.	NULL

2	NULL
,	NULL
pp	NULL
.	NULL

1007-1036	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
35	NULL
.	NULL

Xing	NULL
,	NULL
Y.	NULL
,	NULL
Zhang	NULL
S.	NULL
,	NULL
Olesen	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Rich	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Guarente	NULL
,	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
3009-3013	NULL
36	NULL
.	NULL

McNabb	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Yanyan	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Gurarente	NULL
,	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
47-58	NULL
37	NULL
.	NULL

Maity	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Sinha	NULL
,	NULL
S.	NULL
,	NULL
Ruteshouser	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
and	NULL
de	NULL
Crombrugghe	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
16574-16580	NULL
38	NULL
.	NULL

Sinha	NULL
,	NULL
S.	NULL
,	NULL
Maity	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Lu	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
de	NULL
Crombrugghe	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
1624-1628	NULL
39	NULL
.	NULL

Currie	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
30880-30888	NULL
40	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Otten	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Zufferey	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
75	NULL
,	NULL
185-146	NULL
41	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Siegrist	NULL
,	NULL
C-A	NULL
.	NULL

,	NULL
Mottet	NULL
,	NULL
A.	NULL
,	NULL
Lisowska-Grospierre	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
106-109	NULL
42	NULL
.	NULL

Chang	NULL
,	NULL
C.-H.	NULL
,	NULL
Fontes	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Peterlin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
1367-1374	NULL
43	NULL
.	NULL

Silacci	NULL
,	NULL
P.	NULL
,	NULL
Mottet	NULL
,	NULL
A.	NULL
,	NULL
Steimle	NULL
,	NULL
V.	NULL
,	NULL
Reith	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
1329-1336	NULL
44	NULL
.	NULL

Ge	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
518-523	NULL
45	NULL
.	NULL

Kretzschmar	NULL
,	NULL
M.	NULL
,	NULL
Kaiser	NULL
,	NULL
K.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Meisterernst	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
525-534	NULL
46	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Philbrick	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
and	NULL
Bothwell	NULL
,	NULL
A.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263	NULL
,	NULL
8450-8457	NULL
47	NULL
.	NULL

Soma	NULL
,	NULL
G-L	NULL
,	NULL
Kitahara	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Andoh	NULL
,	NULL
T.	NULL
(	NULL
1984	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

124	NULL
,	NULL
164-171	NULL
48	NULL
.	NULL

Ge	NULL
,	NULL
H.	NULL
,	NULL
Zhao	NULL
,	NULL
Y.	NULL
,	NULL
Chait	NULL
,	NULL
B.	NULL
T.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
12691-12695	NULL
49	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
50	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebowitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1488	NULL
51	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1976	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
,	NULL
248-254	NULL
52	NULL
.	NULL

Parker	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Watson	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Vinograd	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1977	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

74	NULL
,	NULL
851-	NULL
855	NULL
53	NULL
.	NULL

Schroter	NULL
,	NULL
H.	NULL
,	NULL
Maier	NULL
,	NULL
G.	NULL
,	NULL
Ponstingl	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Nordheim	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

4	NULL
,	NULL
3867-3872	NULL
54	NULL
.	NULL

Lai	NULL
,	NULL
J-S.	NULL
,	NULL
and	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
6958-6962	NULL
55	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Barras	NULL
,	NULL
E.	NULL
,	NULL
Zufferey	NULL
,	NULL
M.	NULL
,	NULL
Hadam	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Mach	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
1021-1032	NULL
56	NULL
.	NULL

Fontes	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Jabrane-Rerrat	NULL
,	NULL
N.	NULL
,	NULL
Toth	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
and	NULL
Peterlin	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1966	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188	NULL
,	NULL
2517-2521	NULL
57	NULL
.	NULL

Kaiser	NULL
,	NULL
K.	NULL
,	NULL
Steizer	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Meisterernst	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
8520-8527	NULL
58	NULL
.	NULL

Werten	NULL
,	NULL
S.	NULL
,	NULL
Langen	NULL
,	NULL
F.	NULL
W.	NULL
M.	NULL
,	NULL
van	NULL
Schaik	NULL
,	NULL
R.	NULL
,	NULL
Timmers	NULL
,	NULL
H.	NULL
Th	NULL
.	NULL

M.	NULL
,	NULL
Meisterernst	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
van	NULL
der	NULL
Vliet	NULL
,	NULL
P.	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

276	NULL
,	NULL
367-377	NULL
59	NULL
.	NULL

Malik	NULL
,	NULL
S.	NULL
,	NULL
Guermah	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Nafl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

95	NULL
,	NULL
2192-2197	NULL
60	NULL
.	NULL

Knaus	NULL
,	NULL
R.	NULL
,	NULL
Pollock	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Guarente	NULL
,	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
1983-1996	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Biochemical	NULL
Characterization	NULL
of	NULL
the	NULL
NF-Y	NULL
Transcription	NULL
Factor	NULL
Complex	NULL
during	NULL
B	NULL
Lymphocyte	NULL
Development	NULL
R.	NULL
Alexander	NULL
Currie	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1998	NULL
,	NULL
273:18220-18229.	NULL
doi	NULL
:	NULL
10.1074/jb0.273.29.18220	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/273/29/18220	NULL
Alerts	NULL
:	NULL
Â«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
Â«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
59	NULL
references	NULL
,	NULL
34	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
8220	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

